Document:

<PAGE>

                                                                   EXHIBIT 10.7

                            STOCK PURCHASE AGREEMENT

                                      AMONG

                          COMPOUNDING INNOVATION, INC.

                               CHEMTRUSION, INC.,

                              BPI LIQUIDATION CORP.

                                       AND

                               INTERSYSTEMS, INC.

                         DATED AS OF SEPTEMBER 28, 2001
<PAGE>
                                TABLE OF CONTENTS

<TABLE>
<CAPTION>
                                                                                                                    PAGE
                                                                                                                    ----
<S>      <C>                                                                                                        <C>
1.       PURCHASE AND SALE OF STOCK..............................................................................      1
         1.1.     Distribution by the Company....................................................................      1
         1.2.     Purchase of the Shares.........................................................................      2
         1.3.     Consideration..................................................................................      2

2.       CLOSING.................................................................................................      2
         2.1.     The Closing....................................................................................      2
         2.2.     Deliveries.....................................................................................      2

3.       REPRESENTATIONS AND WARRANTIES OF STOCKHOLDERS..........................................................      3
         3.1.     Due Organization...............................................................................      3
         3.2.     Authorization..................................................................................      3
         3.3.     Capital Stock of the Company...................................................................      4
         3.3.     Encumbrances...................................................................................      4
         3.4.     Obligations to Issue or Sell Stock.............................................................      4
         3.5.     Subsidiaries...................................................................................      4
         3.6.     Corporate History..............................................................................      5
         3.7.     Liabilities and Obligations....................................................................      5
         3.8.     Approvals......................................................................................      5
         3.9.     Intellectual Property..........................................................................      5
         3.10.    Mytex Agreement................................................................................      5
         3.11.    Real and Personal Property.....................................................................      6
         3.12.    Material Contracts and Commitments.............................................................      6
         3.13.    Employees, Consultants, etc....................................................................      7
         3.14.    Benefit Plans; ERISA Compliance................................................................      7
         3.15.    Conformity with Law, Pending or Threatened Claims..............................................     10
         3.16.    Taxes..........................................................................................     10
         3.17.    Completeness...................................................................................     11
         3.18.    Government Contracts...........................................................................     11
         3.19.    Absence of Changes.............................................................................     11
         3.20.    Deposit Accounts; Powers of Attorney...........................................................     13
         3.21.    Conflicts of Interest..........................................................................     13
         3.22.    Environmental Matters..........................................................................     13
         3.23.    Future Relationships...........................................................................     15
         3.24.    Affiliate Contracts and Indebtedness...........................................................     15
         3.25.    Brokerage......................................................................................     15
         3.26.    Solvency.......................................................................................     15
         3.27.    Absence of Certain Commercial Practices........................................................     15
         3.28.    Accounts Payable...............................................................................     16
         3.29.    Suppliers and Customers........................................................................     16
         3.30.    Products.......................................................................................     16
         3.31.    Disclosure.....................................................................................     16

4.       REPRESENTATIONS OF COMPOUNDING INNOVATION...............................................................     16
         4.1.     Authorization..................................................................................     16
</TABLE>

                                       i
<PAGE>
<TABLE>
<S>      <C>                                                                                                          <C>
         4.2.     Approvals......................................................................................     17
         4.3.     Litigation and Administrative Proceedings......................................................     17

5.       CERTAIN COVENANTS OF STOCKHOLDERS, THE COMPANY AND
         COMPOUNDING INNOVATION..................................................................................     17
         5.1.     Access and Cooperation.........................................................................     17
         5.2.     Confidential Information.......................................................................     17
         5.3.     Further Action; Reasonable Commercial Efforts..................................................     18
         5.4.     Cooperation with Litigation....................................................................     18
         5.5.     Releases by Stockholder........................................................................     18
         5.6.     Characterization for Taxation Purposes.........................................................     20
         5.7.     Assumption of 401k Plan........................................................................     20

6.       CONDITIONS PRECEDENT TO OBLIGATIONS OF INTERSYSTEMS AND
         STOCKHOLDERS............................................................................................     21
         6.1.     Representations and Warranties; Performance of Obligations.....................................     21
         6.2.     Counsel Approval...............................................................................     21
         6.3.     Company Distribution...........................................................................     21
         6.4.     No Litigation..................................................................................     21

7.       CONDITIONS TO OBLIGATIONS OF COMPOUNDING INNOVATION.....................................................     21
         7.1.     Representations and Warranties; Performance of Obligations.....................................     21
         7.2.     Counsel Approval...............................................................................     22
         7.3.     No Litigation..................................................................................     22
         7.4.     Opinion of Counsel.............................................................................     22
         7.5.     Consents and Approvals.........................................................................     22
         7.6.     Good Standing Certificates.....................................................................     22
         7.7.     FIRPTA Affidavits..............................................................................     22
         7.8.     Financing......................................................................................     22

8.       INDEMNIFICATION.........................................................................................     23
         8.1.     Survival.......................................................................................     23
         8.2.     Indemnification by Stockholder.................................................................     23
         8.3.     Indemnification by Compounding Innovation......................................................     23
         8.4.     Indemnification Procedures.....................................................................     24

9.       NONCOMPETITION..........................................................................................     26
         9.1.     Prohibited Activities..........................................................................     26
         9.2.     Independent Covenant...........................................................................     27
         9.3.     Materiality....................................................................................     27

10.      CERTAIN DEFINITIONS.....................................................................................     27

11.      GENERAL.................................................................................................     29
         11.1.    Cooperation....................................................................................     29
         11.2.    Designee; Successors and Assigns...............................................................     29
         11.3.    Entire Agreement...............................................................................     29
         11.4.    Counterparts...................................................................................     29
</TABLE>

                                       ii
<PAGE>
<TABLE>
<S>      <C>                                                                                                          <C>
         11.5.    Brokers and Agents.............................................................................     29
         11.6.    Payment of Expenses............................................................................     29
         11.7.    Notices........................................................................................     30
         11.8.    Governing Law..................................................................................     30
         11.9.    Exercise of Rights and Remedies................................................................     30
         11.10.   Time...........................................................................................     30
         11.11.   Reformation and Severability...................................................................     30
</TABLE>

                                      iii
<PAGE>
                             EXHIBITS AND SCHEDULES

<TABLE>
<CAPTION>
EXHIBITS

<S>             <C>
    A    -      Form of Promissory Note
    B    -      Form of Guaranty
</TABLE>

<TABLE>
<CAPTION>
SCHEDULES

<S>                   <C>
Schedule 3.1          Due Organization
Schedule 3.2          Authorization
Schedule 3.3          Capital Stock of the Company
Schedule 3.6          Corporate History
Schedule 3.7          Undisclosed Liabilities
Schedule 3.9          Intellectual Property
Schedule 3.11         Real Property
Schedule 3.11(f)      Encumbrances
Schedule 3.12         Material Contracts
Schedule 3.13         Employment Agreements
Schedule 3.13(c)      Employee Matters
Schedule 3.14         Benefit Plans; ERISA Compliance
Schedule 3.14(c)      ERISA Requirements
Schedule 3.16         Taxes
Schedule 3.20         Deposit Accounts; Powers of Attorney
Schedule 3.21         Conflicts of Interest
Schedule 3.22         Environmental Matters
Schedule 3.24         Affiliate Contracts
Schedule 3.27         Certain Commercial Practices
Schedule 3.28         Accounts Payable
</TABLE>
<PAGE>
                            STOCK PURCHASE AGREEMENT

      THIS STOCK PURCHASE AGREEMENT (the "Agreement") is made as of the 28th day
of September, 2001, among Compounding Innovation, Inc., a Delaware corporation
("Compounding Innovation"), Chemtrusion, Inc., a Delaware corporation
("Company"), InterSystems, Inc., a Delaware corporation ("InterSystems") and BPI
Liquidation Corp., a wholly-owned subsidiary of InterSystems and the sole
stockholder of the Company ("Stockholder"). For purposes of this Agreement,
InterSystems and Stockholder shall be referred to collectively herein as
"Sellers".

      WHEREAS, Stockholder is the owner of all the outstanding common stock,
$.01 par value per share (the "Common Stock"), of the Company; and

      WHEREAS, Stockholder wishes to sell and Compounding Innovation wishes to
purchase all of the issued and outstanding Common Stock of the Company; and

      WHEREAS, the board of directors of the Stockholder has determined that it
is advisable and in the best interest of the shareholders of Stockholder to
effect the sale of all the Common Stock of the Company to Compounding Innovation
upon the terms and conditions set forth herein;

      NOW, THEREFORE, in consideration of the premises and the representations,
warranties, covenants and agreements set forth below, and for other good and
valuable consideration, the receipt and sufficiency of which are hereby
acknowledged, the parties hereto hereby agree as follows:

1.    PURCHASE AND SALE OF STOCK

      (a) DISTRIBUTION BY THE COMPANY. Prior to the Closing and effective on the
Closing Date, the Company shall distribute to Stockholder the right to receive
the Distributed Amount (as defined below). Stockholder and its assigns shall
hold all right, title and interest in the Distributed Amount from and after the
date hereof. For purposes of this Agreement, the Distributed Amount shall mean
for each calendar year prior to January 1, 2007, such amount of the "Management
Fee," as defined in the Mytex Agreement as equals the following amount:

      (i)   for the calendar year 2001, 50% of the Management Fee up to $150,000
            plus the Supplemental Amount; and

      (ii)  for each subsequent calendar year through and including December 31,
            2006 only, 50% of the Management Fee up to an amount equal to: the
            sum of (a) $400,000.00, plus (b) the Supplemental Amount (as defined
            below), if any (the sum of $150,000 plus the Supplemental Amount for
            the year 2001 and the sum of $400,000 plus the Supplemental Amount
            for each year thereafter is referred to as the "Maximum Annual
            Amount").

      The term "Supplemental Amount" means for any calendar year or portion
thereof the sum of the "Monthly Supplemental Amounts" for such calendar year or
portion thereof; the term "Monthly Supplemental Amount" shall mean for a
particular month, the product of
<PAGE>
(x) $33,333.33, times (y) the percentage amount, if any, by which the annual
Fixed Fee (as defined in the Mytex Agreement) in effect on the first (1st) day
of such month exceeds $1,035,000.00. The Company shall timely calculate and
provide to Stockholder the Monthly Supplemental Amount in effect on the first
day of each calendar month prior to December 31, 2006, and shall also provide
copies of all monthly invoices for the Management Fee delivered to Mytex.

      1.1. PURCHASE OF THE SHARES. Subject to the terms and conditions of this
Agreement, Stockholder agrees to sell, transfer and assign to Compounding
Innovation, and Compounding Innovation agrees to purchase from Stockholder, all
of the outstanding shares of the Common Stock of the Company (the "Shares").

      1.2. CONSIDERATION. In consideration of the sale, transfer and delivery of
the Shares, Compounding Innovation shall deliver the following (the "Purchase
Price") at the Closing.

            (a) $400,000 in immediately available funds (the "Closing Cash
Payment");

            (b) a secured subordinated promissory note in the aggregate initial
principal amount of $300,000 accruing interest at a rate of 8% per annum
substantially in the form attached hereto as Exhibit A.

            (c) a Guaranty Agreement substantially in the form attached hereto
as Exhibit B.

The Closing Cash Payment shall be paid to Stockholder by wire transfer at the
Closing (as hereinafter defined) to an account designated by Stockholder at
least three (3) business days prior to the Closing Date.

2.    CLOSING

      2.1. THE CLOSING. The transactions contemplated by this Agreement (the
"Closing") shall take place at 10:00 a.m., Houston time, at the offices of
Mayor, Day, Caldwell & Keeton, L.L.P., 700 Louisiana, Suite 1900, Houston, Texas
77002, on September 28, 2001 (the "Closing Date").

      2.2. DELIVERIES. In addition to the other things required to be done
hereby, at the Closing:

            (a) Stockholder shall deliver or cause to be delivered to
Compounding Innovation the following: (i) the corporate seals and all of the
minute books and stock transfer books of the Company; (ii) certificates
representing the Shares, together with any stock powers endorsed in blank and in
proper form required for their transfer and such other instruments of transfer
and assignment reasonably requested by Compounding Innovation; (iii) a
resignation letter from each of the officers and directors of the Company other
than Scott E. Owens; and (iv) if not previously delivered to Compounding
Innovation, all other certificates and such other instruments and documents
required pursuant hereto or Section 7 of this Agreement to be delivered by or on
behalf of Stockholder at or prior to the Closing, or reasonably requested by
Compounding Innovation in connection herewith.

                                       2
<PAGE>
            (b) Compounding Innovation shall deliver to Stockholder, if not
previously delivered to Stockholder, (i) the Promissory Note, (ii) the Guaranty
and (iii) all certificates and such other instruments and documents required
pursuant hereto or Section 6 of this Agreement to be delivered by or on behalf
of Compounding Innovation at or prior to the Closing, or reasonably requested by
Stockholder in connection herewith.

3.    REPRESENTATIONS AND WARRANTIES OF STOCKHOLDERS

      Stockholder and InterSystems jointly and severally represent and warrant
to Compounding Innovation that each of the following representations and
warranties is true as of the date of this Agreement and shall be true at the
time of the Closing except as (a) otherwise set forth on the Disclosure Schedule
or (b) otherwise actually known on the Closing Date by any member of the
Compounding Innovation Group.

      3.1. DUE ORGANIZATION. The Company is a corporation duly organized,
validly existing and in good standing under the laws of Delaware, and to
Sellers' Knowledge, is duly authorized, qualified and licensed under all
applicable laws, regulations, ordinances and orders of Government Authorities to
own its properties and assets and to carry on its business in the places and in
the manner as it is now conducted, except as disclosed on Schedule 3.1. True and
correct copies of the Company's Certificate of Incorporation, as amended
(certified by the Secretary of State of the State of Delaware) and Bylaws, as
amended (certified by the Secretary of the Company), are attached to Schedule
3.1. The stock records and minute books of the Company, as heretofore made
available to Compounding Innovation, are correct and complete. Stockholder and
InterSystems are corporations duly organized, validly existing and in good
standing under the laws of New York and Delaware, respectively, and are duly
authorized, qualified and licensed under all applicable laws, regulations,
ordinances and orders of Government Authorities to own its properties and assets
and to carry on its business in the places and in the manner as it is now
conducted, except as disclosed on Schedule 3.1. True and correct copies of the
Stockholder's and InterSystems' Certificate of Incorporation, as amended
(certified by the Secretary of State of the State of Delaware) and Bylaws, as
amended (certified by the Secretary of the Stockholder or InterSystems, as
applicable), are attached to Schedule 3.1.

      3.2. AUTHORIZATION. InterSystems, Stockholder and the Company have full
legal right, power and authority to enter into this Agreement and any agreement,
document or certificate contemplated hereby and to perform their obligations
hereunder and to consummate the transactions contemplated hereby. Subject to
Scott E. Owens being in "Control" (as such term is defined in the Mytex
Agreement) of Compounding Innovation and Compounding Innovation electing a
majority of the members of the board of directors of the Company immediately
following the execution and consummation of this Agreement, no consent,
authorization or approval of, filing or registration with, or cooperation from,
any Government Authority or to the knowledge of the Sellers, any other Person
not a party to this Agreement is necessary in connection with the execution,
delivery or performance by InterSystems, the Company or Stockholder of this
Agreement or the consummation of the transactions contemplated hereby. Subject
to Scott E. Owens being in "Control" (as such term is defined in the Mytex
Agreement) of Compounding Innovation and Compounding Innovation electing a
majority of the members of the board of directors of the Company immediately
following the execution and consummation of this Agreement, the execution,
delivery and performance of this Agreement and the consummation of the
transactions contemplated hereby do not and will not (i) violate or conflict

                                       3
<PAGE>
with any provision of InterSystems', the Company's or Stockholder's Certificate
of Incorporation or Bylaws, (ii) violate or conflict with any provision of, or
be an event that is (or with the passage of time will result in) a violation of,
or result in the modification, cancellation or acceleration of (whether after
the giving of notice or lapse of time or both), any obligation under, or result
in the imposition or creation of any Encumbrances upon any of the assets of
InterSystems or Stockholder or, to Sellers' Knowledge, the Company pursuant to
any Contract (as defined in Section 3.12) or any mortgage, lien, lease,
agreement or instrument to which InterSystems or Stockholder or, to Sellers'
Knowledge, the Company is a party or by which InterSystems, Stockholder or, to
Sellers' Knowledge, the Company, is bound, (iii) violate or conflict with any
Legal Requirement applicable to InterSystems or Stockholder or, to the Sellers'
Knowledge, the Company or any of InterSystems' or Stockholder's properties or
assets or any other material restriction of any kind or character to which it or
they are subject or, to the Sellers' Knowledge, any of the Company's properties
or assets or any other material restriction of any kind or character to which it
is subject, or (iv) to Sellers' Knowledge require any authorization, consent,
order, permit or approval of, or notice to, or filing, registration or
qualification with, any Government Authority. This Agreement has been duly
executed and delivered by Stockholder, InterSystems and the Company and,
assuming the due execution and delivery hereof by Compounding Innovation, this
Agreement constitutes the legal, valid and binding obligation of the Company,
InterSystems and Stockholder.

      3.3. CAPITAL STOCK OF THE COMPANY. The authorized capital stock of the
Company consists solely of 1,000 shares of Common Stock, of which 100 shares are
issued and outstanding. All of such issued shares are outstanding and owned of
record and beneficially by Stockholder as set forth on Schedule 3.3 and are free
and clear of all Encumbrances. The Shares have been duly authorized and validly
issued, are fully paid and nonassessable. Upon consummation of this Agreement in
accordance with its terms, Compounding Innovation will acquire good and valid
title in the Shares, free and clear of all Encumbrances. Further, none of such
Shares were issued in violation of the preemptive rights of any past or present
stockholder. Schedule 3.3 contains a true and complete list of all officers and
directors of the Company.

      3.4. OBLIGATIONS TO ISSUE OR SELL STOCK. No right of first refusal,
option, warrant, call, conversion right or commitment of any kind exists which
obligates the Company, or obligates Stockholder to cause the Company, to issue
any capital stock, including its authorized but unissued Common Stock. In
addition, there are no (i) outstanding securities or obligations which are
convertible into or exchangeable for any shares of the capital stock or other
securities of the Company, or (ii) contracts, arrangements or commitments,
written or otherwise, under which the Company is or may become bound to sell or
issue any shares of its capital stock or any other securities. Without limiting
the generality of the foregoing, except as set forth above there is no valid
basis or happening of any event upon which any person (other than Stockholder)
may claim to be in any way the record or beneficial owner, or to be entitled to
acquire (of record or beneficially), any shares of the capital stock or other
securities, of the Company, and no person has made or, to Sellers' Knowledge,
threatened to make any such claim. In addition, except as expressly set forth
herein, the Company has no obligation (contingent or otherwise) to purchase,
redeem or otherwise acquire any of its equity securities or any interests
therein or to pay any dividend or make any distribution in respect thereof.

      3.5. SUBSIDIARIES. To Sellers' Knowledge, the Company does not own, of
record or beneficially, or control, directly or indirectly, any capital stock,
securities convertible or

                                       4
<PAGE>
exchangeable into capital stock or any other equity or other ownership interest
in any corporation, association or other business entity. To Sellers' Knowledge,
the Company is not, directly or indirectly, a participant in any joint venture,
partnership or other noncorporate entity.

      3.6. CORPORATE HISTORY. To Sellers' Knowledge, set forth on Schedule 3.6
is a list of all names of all predecessor companies of the Company, including
the names of any entities from whom the Company previously acquired significant
assets. To Sellers' Knowledge, except as disclosed in Schedule 3.6, the Company
has never been a subsidiary or division of another corporation or other business
entity nor been previously acquired and divested by another corporation.

      3.7. LIABILITIES AND OBLIGATIONS. To Sellers' Knowledge, except as set
forth on the unaudited balance sheet (the "Balance Sheet") as of June 30, 2001
(the "Balance Sheet Date"), or Schedule 3.7, the Company has no liabilities or
obligations of any nature (whether known or unknown, due or to become due,
absolute, accrued, contingent or otherwise, and whether or not determined or
determinable) and there is no existing condition, situation or agreement which
is reasonably likely to result in such a liability or obligation, except for
liabilities or obligations arising since June 30, 2001 in the normal and
customary operation of the Company's business.

      3.8. APPROVALS. No authorization, consent or approval of, or registration
or filing with, any Governmental Authority or any other Person is or was
required to be obtained or made by Stockholder or InterSystems in connection
with the execution, delivery or performance of this Agreement other than
receiving the consent of Stockholders' sole stockholder, and to the Sellers'
Knowledge, no authorization, consent or approval of, or registration or filing
with, any Government Authority or any other Person is or was required to be
obtained or made by the Company in connection with the execution, delivery or
performance of this Agreement.

      3.9. INTELLECTUAL PROPERTY.

            (a) To Sellers' Knowledge, the Company owns or has valid, binding
and enforceable rights to use all patents, trademarks, trade names, service
marks, service names, copyrights, applications for any of the foregoing, and
licenses or other rights in respect of any of the foregoing ("Intellectual
Property"), used or held for use in connection with its business, without any
conflict with the rights of others. To Sellers' Knowledge, except as set forth
on Schedule 3.9, the Company has not received any notice from any other Person
pertaining to or challenging the right of the Company to use any Intellectual
Property or Technology owned or used by or licensed to the Company. To Sellers'
Knowledge, the Company has not granted any outstanding licenses or other rights,
and has no obligation to grant any licenses or other rights, under, and neither
the Stockholder nor InterSystems has any rights in or to, any of the
Intellectual Property or Technology owned or used by or licensed to the Company.
To Sellers' Knowledge, no claims have been made by the Company of any violation
or infringement by others of the rights of the Company with respect to any
Intellectual Property or Technology of the Company, and neither Stockholder nor
InterSystems knows of any basis for the making of any such claim. To Sellers'
Knowledge, neither Stockholder, InterSystems nor the Company has violated or
infringed any Intellectual Property or Technology rights of others.

      3.10. MYTEX AGREEMENT. To Sellers' Knowledge, there exists no default or
any event that, with notice or passage of time could become a default, under any
of the Mytex Agreements.

                                       5
<PAGE>
      3.11. REAL AND PERSONAL PROPERTY.

            (a) To Sellers' Knowledge, Schedule 3.11 sets forth a true, accurate
and complete list of all of the leases of real property ("Real Property Leases")
and all real property owned by the Company (collectively, the "Real Property").
To Sellers' Knowledge, the Real Property constitutes all of the land used by the
Company in the conduct of its business. To Sellers' Knowledge, the Company has
delivered to Compounding Innovation true, accurate and complete copies of the
Real Property Leases, together with copies of all reports (if any) of any
engineers, environmental consultants or other consultants in its possession
relating to any of the Real Property.

            (b) To Sellers' Knowledge, the activities carried on in all
buildings, plants, facilities, installations, fixtures and other structures or
improvements included as part of or located on or at the Real Property, and the
buildings, plants, facilities, installations, fixtures and other structures or
improvements themselves, are not in violation of or in conflict with, any
applicable zoning, environmental or health regulations or ordinance or any other
similar Law.

            (c) To Sellers' Knowledge, all of the Real Property Leases are in
full force and effect, valid and enforceable in accordance with their respective
terms, except as such enforceability may be limited by applicable bankruptcy,
insolvency, moratorium, reorganization or similar laws in effect which affect
the enforcement of creditors' rights generally and by equitable limitations on
the availability of specific remedies. To Sellers' Knowledge other than as set
forth on Schedule 3.11, none of the Real Property Leases have been amended or
modified.

            (d) To Sellers' Knowledge, the Company has not received any notice
of any, and there exists no, dispute, claim, event of default or event which
constitutes or would constitute (with notice or lapse of time or both) a default
under any Real Property Lease.

            (e) To Sellers' Knowledge, Schedule 3.11 sets forth a true, accurate
and complete list of all leases of personal property (whether operating or
capital leases) (the "Personal Property Leases").

            (f) To Sellers' Knowledge, the Company has all the assets, rights
and interests necessary for the uninterrupted conduct of the Company's business
by the Company after the Closing and to Sellers' Knowledge, the Company has good
and valid record and marketable title to all of its assets free and clear of any
Encumbrances other than as set forth on Schedule 3.11(f).

      3.12. MATERIAL CONTRACTS AND COMMITMENTS. To Sellers' Knowledge, Schedule
3.12 sets forth a summary description, complete and correct in all material
respects, of all oral, and an accurate list of all written contracts,
commitments and other agreements to which the Company is a party or by which it
or any of its properties is bound (including, but not limited to, joint venture
or partnership agreements, contracts with any customers, suppliers, employees,
labor organizations, loan agreements, indemnity or guaranty agreements, bonds,
mortgages, leases, licenses, options to purchase real or personal property,
liens, pledges or other security agreements) (herein collectively referred to as
the "Contracts"). To Sellers' Knowledge, the Company has complied in all
material respects with all commitments and obligations pertaining to any such
Contract, and is not in material default under any such Contract and no notice
of default has been received, nor is there any default on the part of any other
party to such Contract,

                                       6
<PAGE>
or any intent of any such party to attempt to terminate or amend any such
Contract. To Sellers' Knowledge, the Company is not bound by or subject to (and
none of its respective assets or properties is bound by or subject to) any
arrangement with any labor union.

      3.13. EMPLOYEES, CONSULTANTS, ETC.

            (a) To Sellers' Knowledge, the Company has delivered to Compounding
Innovation on Schedule 3.13 an accurate and complete Schedule showing all
employment agreements and any other agreements to which the Company is a party
or by which it is bound, containing terms providing for (i) compensation or
other benefits or consequences upon the happening of a change of control of the
Company and (ii) deferred compensation; together in each case with copies of
such plans, agreements and any trusts related thereto, and classifications of
employees covered thereby.

            (b) To Sellers' Knowledge, the Company has fully complied with the
verification requirements and the recordkeeping requirements of the Immigration
Reform and Control Act of 1986 ("IRCA"); the information and documents on which
the Company relied in complying with IRCA are true and correct; and there have
not been any discrimination complaints filed against the Company pursuant to
IRCA.

            (c) To Sellers' Knowledge and other than as set forth on Schedule
3.13(c), no employees of the Company are represented by any labor union or
covered by any collective bargaining agreement nor is involved in any campaign
to establish such representation in progress.

            (d) To Sellers' Knowledge, the Company has not received or been
notified of any complaint by any employees, applicant, union, or other party of
any discrimination or other conduct forbidden by law.

            (e) To Sellers' Knowledge, the Company has filed all required
reports and information that are due prior to the Closing Date and otherwise has
complied with all applicable regulatory requirements within the jurisdiction of
the United States Equal Employment Opportunity Commission, the United States
Department of Labor and state and local human rights and/or civil rights
agencies.

            (f) To Sellers' Knowledge, the Company has not received or been
notified or any intention by any of its employees to terminate his or her
employment or to seek a modification in the terms of his or her employment,
individually or collectively with other employees.

      3.14. BENEFIT PLANS; ERISA COMPLIANCE.

            (a) To Sellers' Knowledge, Schedule 3.14 contains a list of all
"employee pension benefit plans" (as defined in Section 3(2) of Employee
Retirement Income Security Act of 1974, as amended ("ERISA")) (sometimes
referred to in this Section 3.17 as "Pension Plans"), "employee welfare benefit
plans" (as defined in Section 3(1) of ERISA) (sometimes referred to in this
Section 3.17 as "Welfare Plans") and all other Benefit Plans, as defined below,
currently maintained in whole or in part, contributed to, or required to be
contributed to by the Company for the benefit of any present or former officer,
employee, consultant, agent or director of the Company. For purposes of this
Agreement, the term "Benefit Plan" shall mean any collective

                                       7
<PAGE>
bargaining agreement or any bonus, pension, profit sharing, deferred
compensation, incentive compensation, stock ownership, stock purchase, stock
option, phantom stock, retirement, vacation, severance, disability, death
benefit, hospitalization, medical or health care, life insurance, dependent
care, cafeteria, employee assistance, scholarship or other plan, program,
arrangement or understanding (whether or not legally binding) maintained in
whole or in part, contributed to, or required to be contributed to by the
Company for the benefit of any present or former officer, employee, consultant,
agent or director of the Company. To Sellers' Knowledge, the Company has
delivered to Compounding Innovation true, complete and correct copies of any of
the following received by Stockholder or InterSystems or in the possession of
Stockholder or InterSystems: all correspondence and filings for the last three
(3) years prior to the Closing Date with the IRS, the United States Department
of Labor, or the Pension Benefit Guaranty Corporation relating to plan
qualification, filing of required forms, pending, contemplated or announced plan
audits with respect to any Benefit Plan, if any.

            (b) To Sellers' Knowledge, each Benefit Plan intended to be
tax-qualified under Section 401(a) of the Internal Revenue Code of 1986, as
amended (the "Code"), (i) has received a favorable determination letter from the
Internal Revenue Service as to its tax-qualified status under the Code and
nothing has occurred since the date of such favorable determination letter which
would adversely affect the qualified status of such plan or (ii) is a
standardized prototype as defined in the Code. To Sellers' Knowledge, neither
the Company nor any person, whether or not incorporated, which is deemed to be
under common control (as defined in Section 414 of the Code) with the Company
has ever maintained, contributed to, or had an obligation to contribute to any
plan subject to the minimum funding rules of Code Section 412 or ERISA Section
302 or Title IV of ERISA.

            (c) Except as set forth on Schedule 3.14(c), each of the Benefit
Plans sponsored by, and each of the benefit plans formerly sponsored by, the
Company: (i) has been in substantial compliance with all reporting and
disclosure requirements of (x) Title I of ERISA, if applicable, or (y) other
applicable law, (ii) has had the appropriate required Form 5500 (or equivalent
annual report) filed timely with the appropriate governmental entity for each
year of its existence, (iii) has at all times complied with the bonding
requirements of (x) Section 412 of ERISA, if applicable, or (y) other applicable
law, (iv) has no issue pending (other than the payment of benefits in the normal
course) nor any issue resolved adversely to the Company which may subject the
Company to the payment of material penalty, interest, tax or other obligation,
nor is there any basis for any imposition of any such liability, and (v) has
been maintained in all respects in compliance with the applicable requirements
of ERISA, the Code and other applicable law not otherwise covered hereunder so
as not to give rise to any liabilities to the Company which would, individually
or in the aggregate, have a Material Adverse Effect.

            (d) There are no voluntary employee benefit associations maintained
by the Company and intended to be exempt from federal income tax under Section
501(c)(9) of the Code.

            (e) The execution of this Agreement or the consummation of the
transactions contemplated by this Agreement will not give rise to any, or
trigger any, change of control, severance or other similar provisions in any
Benefit Plan. The consummation of any transaction contemplated by this Agreement
will not result in any (i) payment (whether of severance pay or otherwise)
becoming due from the Company to any officer, employee, former employee or

                                       8
<PAGE>
director thereof or to the trustee under any "rabbi trust" or similar
arrangement; (ii) benefit under any Benefit Plan of the Company being
established or becoming accelerated, vested or payable; or (iii) payment or
series of payments by the Company, directly or indirectly, to any person that
would constitute a "parachute payment" within the meaning of Section 280G of the
Code.

            (f) To Sellers' Knowledge, the Company provides no post-retirement
medical, health, disability or death protection coverage or contributes to or
maintains any Benefit Plan which provides for medical, health, disability or
death benefit coverage following termination of employment by any officer,
director or employee except as is required by Section 4980B(f) of the Code or
other applicable statute, nor has it made any representations, agreements,
covenants or commitments to provide that coverage.

            (g) Except as set forth in Schedule 3.14, to Sellers' Knowledge,
none of the Company, any officer of the Company or any Benefit Plan which is
subject to ERISA, or any trusts created thereunder, or any trustee or
administrator thereof, has engaged in a "prohibited transaction" (as such term
is defined in Section 406, 407 or 408 of ERISA or Section 4975 of the Code) or
any other breach of fiduciary responsibility that could subject the Company or
any officer of the Company to the tax or penalty on prohibited transactions
imposed by such Section 4975 of the Code or to any liability under Section
502(i) or (1) of ERISA which would individually or in the aggregate have a
Material Adverse Effect. No "reportable event" (as that term is defined in
Section 4043 of ERISA) with respect to which the 30-day notice requirement has
not been waived has occurred and is continuing with respect to any such Pension
Plan, other than as may arise as a result of the consummation of the
transactions contemplated by this Agreement.

            (h) Except as set forth in Schedule 3.14, to Sellers' Knowledge with
respect to any Welfare Plan, (i) each such Welfare Plan that is a group health
plan, as such term is defined in Section 5000(b)(1) of the Code, complies in all
material respects with any applicable requirements of Part 6 of Title I of ERISA
and Section 4980B(f) of the Code and (ii) each such Welfare Plan (including any
such plan covering retirees or other former employees) may be amended or
terminated with respect to health benefits without material liability to the
Company on or at any time after the Closing Date.

            (i) Except as set forth in Schedule 3.14, to Sellers' Knowledge, all
contributions required by law or by a collective bargaining or other agreement
to be made under the Benefit Plans with respect to all periods through the
Closing Date, will have been timely made. To Sellers' Knowledge, no changes in
contribution rates or benefit levels have been announced, implemented or
negotiated (but not yet implemented), with respect to any Benefit Plan or new
benefit plan since the date on which the information provided in the attached
SCHEDULE has been provided, and no such changes are Scheduled to occur.

            (j) Except as set forth in Schedule 3.14, the Company has not and
will not have any liability or obligation for taxes, penalties, contributions,
losses, claims, damages, judgments, settlement costs, expenses, costs, or any
other liability or liabilities of any nature whatsoever arising out of or in any
manner relating to any Benefit Plan (including but not limited to employee
benefit plans such as foreign plans which are not subject to ERISA), that has
been, or is, contributed to by any person, whether or not incorporated, which is
deemed to be under common control (as defined in Section 414 of the Code) with
the Company.

                                       9
<PAGE>
            (k) For purposes of this Section 3.14, all representations and
warranties in subsections (c), (d), (e), (j) and the last sentence in subsection
(g) shall be (i) qualified to the Sellers' Knowledge with respect to any Benefit
Plan which relate to any fact, filing or action related to any period after
January 1, 2000 and (ii) qualified to the Sellers' Knowledge with respect to any
Benefit Plan other than the InterSystems, Inc.'s 401(k) Savings and Profit
Sharing Plan with respect to any period before January 1, 2000.

      3.15. CONFORMITY WITH LAW, PENDING OR THREATENED CLAIMS. To Sellers'
Knowledge, (i) the Company has complied with, and the Company is not in default
under, any law, rule, ordinance, ruling, directive, or regulation or under any
order, award, judgment or decree of any court or federal, state, municipal or
other governmental department, commission, board, bureau, agency or
instrumentality having jurisdiction over the Company, any of its assets or its
business; and (ii) there are no claims, actions, suits or proceedings, pending
or threatened, against or affecting the Company, at law or in equity, or before
or by any court or federal, state, municipal or other governmental department,
commission, board, bureau, agency or instrumentality having jurisdiction over
the Company or its business and no notice of any claim, action, suit or
proceeding, whether pending or threatened, has been received. To Sellers'
Knowledge, the Company has conducted and is conducting its business in full
compliance with the requirements, standards, criteria and conditions set forth
in applicable federal, state and local statues, ordinances, permits, licenses,
orders, approvals, variances, rules and regulations, including, without
limitation, all such laws, rules, ordinances, decrees and orders relating to
intellectual property protection, antitrust matters, consumer protection,
currency exchange, environmental protection, equal employment opportunity,
health and occupational safety, pension and employee benefit matters, securities
and investor protection matters, labor and employment matters (including without
limitation, plant closing or mass layoff matters), and trading-with-the-enemy
matters. To Sellers' Knowledge, neither the Company, InterSystems nor
Stockholder have received any notification of any asserted present or past
unremedied failure by the Company to comply with any of such laws, rules,
ordinances, decrees or orders.

      3.16. TAXES.

            (a) Except as set forth on Schedule 3.16, the Company has timely
filed all federal income tax returns and paid all Taxes due thereunder and to
the Sellers' Knowledge, has timely filed all other Tax Returns which are
required to be filed and to Sellers' Knowledge, paid all Taxes due thereunder;
and except as set forth on Schedule 3.16, to the Sellers' Knowledge, there are
no waivers or extensions of the statute of limitations, pending audits or
judicial proceedings, examinations in progress or claims against the Company
with respect to Taxes (including penalties and interest) and no notice of any
claim, whether pending or threatened, for Taxes has been received and not paid.
The Company is not a party to any Tax allocation or sharing agreement or Tax
indemnity agreement which would require it to make any payment to any other
person by reason of any Tax imposed on any such person. There are no requests
for rulings in respect of any Tax pending by the Company with any taxing
authority; and no penalty or deficiency in respect of any Taxes which has been
assessed against the Company remains unpaid. Stockholder has provided to
Compounding Innovation copies of all federal income Tax Returns and all other
Tax Returns in its possession of the Company for the last three taxable years,
and all Tax Returns related to federal income tax are true, correct and complete
except to the extent such inaccuracy was due to the negligence of Scott E. Owens
or any employee of the Company that reports directly or indirectly to Scott E.
Owens. To Sellers' Knowledge all other

                                       10
<PAGE>
Tax Returns are true, accurate and complete. For purposes of this Agreement,
"Tax" shall mean any United States or other federal, state, provincial, local or
foreign income, gross receipts, property, sales, goods and services use,
license, excise, franchise, employment, payroll, withholding, alternative or
add-on minimum, ad valorem, transfer or excise tax, or any other tax, custom,
duty, governmental fee or other like assessment or charge of any kind
whatsoever, together with any interest or penalty, imposed by any governmental
authority. "Tax Return" shall mean any return, report or similar statement
required to be filed with respect to any Tax (including any attached Schedules),
including, without limitation, any information return, claim for refund, amended
return and declaration of estimated Tax.

            (b) Stockholder is not a foreign person subject to withholding under
Section 1445 of the Code and the regulations promulgated thereunder, and
certification to that effect will be delivered to Compounding Innovation at the
Closing.

            (c) To Sellers' Knowledge, the Company has complied in all material
respects with all applicable laws, rules and regulations relating to information
reporting with respect to payments made to third parties and the withholding of
and payment of withheld Taxes and has timely withheld from employee wages and
other payments and paid over to the proper taxing authorities all amounts
required to be so withheld and paid over for all periods under all applicable
laws or it has finally resolved and fully satisfied any liability for any
failure to comply with any such matters.

            (d) To Sellers' Knowledge, there is no pending claim by any taxing
authority in any jurisdiction in which the Company does not pay Taxes or file
Tax Returns that the Company is required to pay Taxes or file Tax Returns.

            (e) The Company has not made an election under Section 341(f) of the
Code.

            (f) The Company has not agreed nor is it required to make any
adjustment under Section 481(a) of the Code.

            (g) The statements made in the affidavits to be delivered at closing
pursuant to Section 7 are true and correct.

      3.17. COMPLETENESS. The certified copies of the Articles of Incorporation
and Bylaws, both as amended to date, of the Company, InterSystems and
Stockholder attached hereto as Schedule 3.1, and to the Sellers' Knowledge, the
copies of all leases, instruments, agreements, licenses, permits, certificates
or other documents which are included on, attached to or delivered with
Schedules referred to in this Agreement or were otherwise delivered to
Compounding Innovation pursuant to the provisions of this Agreement are complete
and correct.

      3.18. GOVERNMENT CONTRACTS. To Sellers' Knowledge, the Company is not now
and has never been a party to any governmental contract subject to price
redetermination or renegotiation.

      3.19. ABSENCE OF CHANGES. To Sellers' Knowledge, since the Balance Sheet
Date except as expressly contemplated by this Agreement, there has not been:

                                       11
<PAGE>
            (a) any material adverse change in the financial condition, assets,
liabilities (contingent or otherwise), income or business of the Company other
than the losses in connection with the operation of the Houston division;

            (b) any damage, destruction or loss (whether or not covered by
insurance) materially adversely affecting the properties or business of the
Company;

            (c) any change in the authorized capital of the Company or its
securities outstanding or any change in the ownership interests or any grant of
any options, warrants, calls, conversion rights or commitments;

            (d) any declaration or payment of any dividend or distribution in
respect of the capital stock of the Company or any direct or indirect
redemption, purchase or other acquisition of any of the capital stock of the
Company except as contemplated by Section 1.1 of this Agreement;

            (e) any material increase or promise of an increase in the
compensation, bonus, sales commissions, fringe benefits or fee arrangement
payable or to become payable by the Company to any of its officers, directors,
stockholders, employees, consultants or agents or any change in the method by
which any of such payments are calculated and paid;

            (f) any work interruptions, labor grievances or claims filed or any
proposed law or regulation or any event or condition of any character,
materially adversely affecting the business or future prospects of the Company;

            (g) any sale or transfer, or any agreement to sell or transfer, any
material assets, property or rights of the Company to any Person, including,
without limitation, the Stockholder and its affiliates;

            (h) other than in the ordinary course of business as a result of the
actions or decisions of a member of the Compounding Innovation Group any
cancellation, or agreement to cancel, any indebtedness or other obligation owing
to the Company, including without limitation any indebtedness or obligation of
Stockholder or any affiliate thereof;

            (i) any plan, agreement or arrangement granting any preferential
rights to purchase or acquire any interest in any of the assets, property or
rights of the Company or requiring consent of any party to the transfer and
assignment of any such assets, property or rights;

            (j) other than in the ordinary course of business as a result of the
actions or decisions of a member of the Compounding Innovation Group any
purchase or acquisition, or agreement, plan or arrangement to purchase or
acquire, any property, rights or assets;

            (k) any waiver of any material rights or claims of the Company;

            (l) any breach, amendment or termination of any material contract,
agreement, license, permit or other right to which the Company is a party
including the Mytex Agreement;

                                       12
<PAGE>
            (m) any transaction by the Company outside the ordinary course of
its business and consistent with past practice except the Sixth Amendment to the
Mytex Agreement; or

            (n) any authorization, approval, agreement or commitment to do any
of the foregoing.

      3.20. DEPOSIT ACCOUNTS; POWERS OF ATTORNEY. To Sellers' Knowledge,
Schedule 3.20 sets forth an accurate list of:

            (a) the name of each financial institution in which the Company has
accounts or safe deposit boxes;

            (b) the names in which the accounts or boxes are held;

            (c) the type of account; and

            (d) the name of each person authorized to draw thereon or have
access thereto.

To Sellers' Knowledge, Schedule 3.20 also sets forth the name of each person,
corporation, firm or other entity holding a general or special power of attorney
from the Company and a complete description of the terms of such power. Each
such power has been or will be canceled on or before the Closing Date.

      3.21. CONFLICTS OF INTEREST. Except as disclosed in Schedule 3.21 and
other than transactions with the members of Compounding Innovation Group, to
Sellers' Knowledge, neither (a) any past or present officer or director of the
Company, nor (b) any relative of any past or present officer or director of the
Company, nor (c) any corporation, partnership, trust or other entity in which
any such past or present officer or director of the Company has a direct or
indirect interest or of which he is a director, officer, stockholder, partner or
trustee, is or has been within the eighteen (18) months prior to the date
hereof, a party, directly or indirectly, to any transaction with the Company,
including without limitation any agreement or other arrangement providing for
the furnishing of services by or to the Company or the rental of any property
from or to the Company, or otherwise requiring or contemplating any payments by
or to the Company. Except as disclosed in Schedule 3.21, neither any present
officer or director, nor any relative of any such officer or director, owns
directly or indirectly any interest in any corporation, firm, partnership, trust
or other entity or business which is a competitor, potential competitor,
customer, client or supplier of the Company or any related business.

      3.22. ENVIRONMENTAL MATTERS. To Sellers' Knowledge, except as referenced
on SCHEDULE 3.22:

            (a) the Company holds, and is in compliance with and has been in
compliance with, all Environmental Permits and is otherwise in compliance with,
and has been in compliance with, all applicable Environmental Laws, and there is
no condition that is reasonably likely to prevent or interfere with compliance
by the Company with any Environmental Law or will give rise to any investigatory
or remedial obligations either onsite or offsite the properties owned, operated
or otherwise used by the Company;

                                       13
<PAGE>
            (b) the Company has not received any Environmental Claim, nor has
any Environmental Claim been threatened in writing against the Company nor is
any suit, action or proceeding alleging a violation of an Environmental Law
pending or threatened against the Company;

            (c) the Company has not entered into, agreed to or is subject to any
outstanding judgment, decree, order or other directive issued by, or consent
arrangement with, any Government Authority under any Environmental Law,
including any such judgment, decree, order or other directive relating to
compliance with any Environmental Law or to the investigation, cleanup,
remediation or removal of Hazardous Substances;

            (d) there are no underground storage tanks beneath the properties
owned, leased, operated or otherwise used by the Company and no underground
storage tanks were previously located beneath such properties that have since
been abandoned in place or removed from the ground;

            (e) there are no circumstances that could reasonably be expected to
give rise to liability under any agreements with any Person under which the
Company would be required to defend, indemnify, hold harmless, or otherwise be
responsible for any violation by or other liability or expense of such Person,
or alleged violation by or other liability or expense of such Person, arising
under any Environmental Law; and

            (f) there are no other circumstances or conditions that are
reasonably likely to give rise to a liability or obligation of the Company under
any Environmental Law.

      For purposes of this Section,

      "Environmental Claim" means any claim by a Person alleging or imposing
actual or potential liability (including potential liability for any
investigatory cost, containment cost, control cost, remediation cost, cleanup
cost, governmental response cost, natural resources damage, property damage,
personal injury or penalty) arising out of, based on, resulting from or relating
to (i) the presence, storage, transport, disposal, arrangement for transport,
arrangement for disposal, use, discharge, release or threatened release of any
Hazardous Substance at any location, whether or not owned by the Person against
whom the claim is made, or (ii) circumstances forming the basis for any
liability under, or any violation or alleged violation of, any Environmental
Law.

      "Environmental Laws" means all applicable U.S. federal, state, local and
other Laws (and administrative or judicial interpretations by any Governmental
Entity having the force and effect of Law) relating to pollution or the
protection of human health and safety from the effects of pollution or the
environment (which includes its ambient air, surface water, ground water, land
surface and subsurface strata), including Laws relating to emissions,
discharges, releases or threatened releases of Hazardous Substances, or
otherwise relating to the manufacture, processing, distribution, use, existence,
treatment, storage, disposal, arrangement for transport, arrangement for
disposal, transport, reporting or handling of Hazardous Substances, but not
including zoning and land use Laws.

      "Environmental Permits" means all permits, licenses, registrations,
certifications, exemptions, approvals and other authorizations of or by any
Governmental Entity required under

                                       14
<PAGE>
any Environmental Law for the Company to conduct its operations consistent with
past or current practices.

      "Hazardous Substances" means chemicals, pollutants, contaminants, wastes
(including ambient wastes, hazardous wastes and liquid industrial wastes), or
other substances (including toxic, deleterious or hazardous substances), as
defined or regulated pursuant to Environmental Laws, including asbestos or
asbestos-containing materials, polychlorinated biphenyls, pesticides and oils,
and petroleum and petroleum products (as those exemplary terms are defined in or
regulated under the United States National Oil and Hazardous Substances
Pollution Contingency Plan, 40 C.F.R. Section 300.1 et. seq. or other
Environmental Laws).

      3.23. FUTURE RELATIONSHIPS. To Sellers' Knowledge, there are no facts,
circumstances, or conditions which, individually or in the aggregate would cause
any material customer of the Company to discontinue its relationship with the
Company after the Closing.

      3.24. AFFILIATE CONTRACTS AND INDEBTEDNESS. Schedule 3.24 sets forth a
true and complete list of all contracts, indebtedness and other obligations or
liabilities between the Company and Stockholder or InterSystems or any of
Stockholder's or InterSystems' Affiliates (other than Compounding Innovation or
Scott E. Owens). Copies of all documents related to all such contracts,
indebtedness and other obligations or liabilities (including any obligations to
pay salary, bonus, other compensation, expense reimbursements, or other
perquisites or benefits) have been furnished to Compounding Innovation.

      3.25. BROKERAGE. None of the Company, InterSystems or Stockholder has
dealt with, or is obligated to make any payment to, any finder, broker,
investment banker, or financial advisor in connection with any of the
transactions contemplated by this Agreement or the negotiations looking toward
the consummation of such transactions.

      3.26. SOLVENCY. None of the Stockholder or InterSystems (a) is or after
consummation of the transactions contemplated hereby will be, "insolvent" (as
such term is defined in Section 101(32)(A) of the Federal Bankruptcy Code, (b)
is unable to pay and is paying its debts as they mature, and (c) has and after
consummation of the transactions contemplated hereby will have, unreasonably
small capital for the business in which it is engaged or for any business or
transaction in which it is about to engage.

      3.27. ABSENCE OF CERTAIN COMMERCIAL PRACTICES. To Sellers' Knowledge,
except as set forth on SCHEDULE 3.27, neither Stockholder, InterSystems the
Company, nor any officer, director, employee or agent of the Stockholder,
InterSystems or Company (nor any person acting on behalf of any of the
foregoing) has given or agreed to give any gift or similar benefit of more than
nominal value to any customer, supplier, governmental employee or official or
any other person who is or may be in a position to help, hinder or assist the
Company or the person giving such gift or benefit in connection with any actual
or proposed transaction relating to the Company, which gifts or similar benefits
would individually or in the aggregate subject the Company or any officer,
director, employee or agent of the Company to any fine, penalty, cost or expense
or to any criminal sanctions. To Sellers' Knowledge, no such gift or benefit is
required in connection with the operations of the Company to avoid any fine,
penalty, cost, expense or adverse effect on the financial condition of the
Company.

                                       15
<PAGE>
      3.28. ACCOUNTS PAYABLE. To Sellers' Knowledge, Schedule 3.28 contains a
true and complete aged list of the most recent accounting month end of the
Company prior to the date hereof of (a) all accounts payable of the Company, and
(b) accrued liabilities and the aggregate amounts thereof. To Sellers'
Knowledge, as of the Closing, all such Accounts Payable will have been incurred
in bona fide transactions in the ordinary course of the business, and there will
be no agreement between the Company and any creditor regarding the extension of
the terms of any payment of such Accounts Payable.

      3.29. SUPPLIERS AND CUSTOMERS. Since January 1, 2001, to Sellers'
Knowledge, there has not been any material adverse change in the business
relationship of the Company with any of the significant suppliers or customers
of the Company.

      3.30. PRODUCTS. To Sellers' Knowledge, there are no claims pending or
threatened, against the Company with respect to the manufacture or sale or
products of the Company manufactured or sold by the Company, nor do the Sellers
have any knowledge of a basis for such a claim.

      3.31. DISCLOSURE. To Sellers' Knowledge, this Agreement and the Schedules
hereto and all other documents included on, attached to or delivered with the
Schedules hereto or which were otherwise delivered to Compounding Innovation
pursuant to the provisions of this Agreement do not include any untrue statement
of a material fact or omit to state a material fact necessary to make the
statements therein not misleading.

4.    REPRESENTATIONS OF COMPOUNDING INNOVATION

      Compounding Innovation represents and warrants to the Stockholder as
follows:

      4.1. AUTHORIZATION. Compounding Innovation is a corporation duly
organized, validly existing and in good standing under the laws of Delaware, and
is duly authorized, qualified and licensed under all applicable laws,
regulations, ordinances, and orders of Governmental Authorities to own its
properties and assets and carry on its business in places and in the manner as
it is now conducted. Compounding Innovation has full legal right and power to
enter into this Agreement and to perform its obligations hereunder and to
consummate the transactions contemplated hereby. The execution, delivery and
performance of this Agreement and the consummation of the transactions
contemplated hereby do not and will not (i) violate or conflict with any
provision of, or be an event that is (or with the passage of time will result
in) a violation of, or result in the modification, cancellation or acceleration
of (whether after the giving of notice or lapse of time or both), any obligation
under, or result in the imposition or creation of any Encumbrances upon any of
the assets of Compounding Innovation pursuant to any Contract (as defined in
Section 3.12) or any mortgage, lien, lease, agreement or instrument to which
Compounding Innovation is a party or by which Compounding Innovation is bound,
(ii) violate or conflict with any Legal Requirement applicable to Compounding
Innovation or any of its properties or assets or any other material restriction
of any kind or character to which it or they are subject, or (iii) require any
authorization, consent, order, permit or approval of, or notice to, or filing,
registration or qualification with, any Government Authority. This Agreement has
been duly executed and delivered by Compounding Innovation and, assuming the due
execution and delivery hereof by the Company and Stockholder, this Agreement
constitutes the legal, valid and binding obligation of Compounding Innovation.

                                       16
<PAGE>
      4.2. APPROVALS. No authorization, consent or approval of, or registration
or filing with, any Governmental Authority or any other Person is or was
required to be obtained or made by Compounding Innovation in connection with the
execution, delivery or performance of this Agreement. To Compounding Innovation'
Knowledge, no authorization, consent or approval of, or registration or filing
with, any Government Authority or any other Person is or was required to be
obtained or made by the Company in connection with the execution, delivery or
performance of this Agreement.

      4.3. LITIGATION AND ADMINISTRATIVE PROCEEDINGS. There is no litigation,
proceeding or investigation pending or, to the knowledge of Compounding
Innovation, threatened against Compounding Innovation in any federal, state or
local court, or before any administrative agency, that seeks to enjoin or
prohibit, or otherwise questions the validity of, any action taken or to be
taken pursuant to or in connection with this Agreement.

      4.4. INVESTMENT. Compounding Innovation is acquiring the Shares for
investment for its own account, and not with the view to, or for resale in
connection with, any distribution of any part thereof, and it has no present
intention of selling, granting any participation in or otherwise distributing
the Shares. Compounding Innovation understands that the Shares to be purchased
have not been registered under the Securities Act of 1933, as amended, or
applicable state and other securities laws by reason of a specific exemption
from the registration provisions of the Securities Act and applicable state and
other securities laws, the availability of which depends upon, among other
things, the bona fide nature of the investment intent and the accuracy of
Compounding Innovation's representations as expressed herein.

5.    CERTAIN COVENANTS OF STOCKHOLDERS, THE COMPANY AND COMPOUNDING INNOVATION

      5.1. ACCESS AND COOPERATION. Between the date of this Agreement and the
Closing Date, Stockholder and the Company will afford to Compounding Innovation
and the authorized representatives of Compounding Innovation access to all of
the Company's sites, properties, books and records and will furnish Compounding
Innovation with such additional financial and operating data and other
information as to the business and properties of the Company as Compounding
Innovation may from time to time reasonably request. The Company will cooperate
with Compounding Innovation, its representatives, engineers, auditors and
counsel in the preparation of any documents or other material which may be
required in connection with any documents or materials required by any
governmental agency. Compounding Innovation will cause all information obtained
in connection with the negotiation and performance of this Agreement to be
treated as confidential.

      5.2. CONFIDENTIAL INFORMATION. Stockholder recognize and acknowledge that
they have in the past, currently have, and in the future may possibly have,
access to certain confidential information of the Company, such as lists of
employees, customers, operational policies, and pricing and cost policies that
are valuable, special and unique assets of the Company and the Company's
business. Stockholder and InterSystems agree that they will not disclose such
confidential information to any Person for any purpose or reason whatsoever,
except to authorized representatives of Compounding Innovation, unless (a) such
information becomes known to the public generally through no fault of a
Stockholder or InterSystems or (b) counsel for Stockholder or InterSystems
reasonably and in good faith advises Stockholder such

                                       17
<PAGE>
information must be disclosed by law or in any arbitration or litigation between
Stockholder or InterSystems and Compounding Innovation or any of its affiliates;
provided, however, that in either such case Stockholder or InterSystems, as
applicable, shall to the extent practicable consult with Compounding Innovation
in advance of such disclosure and use reasonable efforts to obtain such
protective treatment for the information as is reasonably available under the
circumstances. In the event of a breach or threatened breach by Stockholder or
InterSystems of the provisions of this Section 5.2, Compounding Innovation shall
be entitled to an injunction restraining Stockholder or InterSystems, as
applicable, from disclosing, in whole or in part, such confidential information.
Nothing herein shall be construed as prohibiting Compounding Innovation and the
Company from pursuing any other available remedy for such breach or threatened
breach, including the recovery of damages. Prior to the Closing, Stockholder and
InterSystems will request and use reasonable efforts to ensure that each party
to whom it has sent confidential information related to the Company (whether
pursuant to a confidentiality arrangement or otherwise) return and/or destroy
such information and all copies thereof and notes or documents related thereto.

      5.3. FURTHER ACTION; REASONABLE COMMERCIAL EFFORTS. Subject to the terms
and conditions hereof, each party hereto shall use its reasonable commercial
efforts to take, or to cause to be taken, all appropriate action, and to do, or
to cause to be done, all things necessary, proper or advisable under applicable
Laws to consummate and make effective the transactions contemplated hereby.

      5.4. COOPERATION WITH LITIGATION. PLAINTIFF.

            (a) After the Closing Date, the Company shall cooperate with
Stockholder and InterSystems and give Stockholder and InterSystems reasonable
access during normal business hours to all properties, operations, books,
records, contracts, and documents of the Company relating to (i) proceedings set
forth on the Disclosure Schedule, (ii) any subsequent litigation related to the
Company or (iii) any preparation or audit of any Tax Return and shall furnish
and request its accountants and outside legal counsel to furnish to Stockholder
and InterSystems all information with respect to such proceedings or preparation
as Stockholder and InterSystems may reasonably request. Stockholder and
InterSystems shall also have the right to discuss such proceedings and tax
returns with the employees of the Company after the Closing Date;

            (b) After the Closing Date, Stockholder and InterSystems shall
cooperate with the Company and give Company reasonable access during normal
business hours to all properties, operations, books, records, contracts, and
documents of the Stockholder and/or InterSystems relating to (i) proceedings set
forth on the Disclosure Schedule, (ii) any subsequent litigation related to the
Company or (iii) any preparation or audit of any Tax Return and shall furnish
and request its accountants and outside legal counsel to furnish to Company all
information with respect to such proceedings or preparation as Company may
reasonably request. Company shall also have the right to discuss such
proceedings and tax returns with the employees of the Stockholder and/or
InterSystems after the Closing Date.

      5.5. RELEASES BY STOCKHOLDER. (a) STOCKHOLDER HEREBY AGREES AND CONFIRMS
THAT EFFECTIVE FROM AND AFTER THE CLOSING, IT HEREBY FULLY RELEASES, ACQUITS AND
FOREVER DISCHARGES THE COMPANY, TOGETHER WITH ITS OFFICERS AND DIRECTORS,
SUCCESSORS, ASSIGNS, AFFILIATES, AND

                                       18
<PAGE>
PARENT (INCLUDING, WITHOUT LIMITATION, COMPOUNDING INNOVATION AND SCOTT E.
OWENS), FROM ANY AND ALL LIABILITY, CLAIM, DAMAGE, SUIT, COST, EXPENSE OR
OBLIGATION OF ANY NATURE WHATSOEVER, WHETHER KNOWN OR UNKNOWN, ARISING IN
RESPECT OF OR IN CONNECTION WITH ANY TIME OR PERIOD OF TIME ON OR PRIOR TO THE
CLOSING DATE, EXCEPT WITH RESPECT TO OBLIGATIONS ARISING UNDER THIS AGREEMENT
AND DOCUMENTS EXECUTED IN CONNECTION WITH THIS AGREEMENT INCLUDING WITHOUT
LIMITATION THAT CERTAIN MEMORANDUM OF UNDERSTANDING OF EVEN DATE HEREWITH AND
THE CONFIDENTIALITY AGREEMENT OF EVEN DATE HEREWITH BY AND AMONG INTERSYSTEMS,
BPI AND SCOTT E. OWENS.

            (b) INTERSYSTEMS HEREBY AGREES AND CONFIRMS THAT EFFECTIVE FROM AND
AFTER THE CLOSING, IT HEREBY FULLY RELEASES, ACQUITS AND FOREVER DISCHARGES THE
COMPANY, TOGETHER WITH ITS OFFICERS AND DIRECTORS, SUCCESSORS, ASSIGNS,
AFFILIATES, AND PARENT (INCLUDING, WITHOUT LIMITATION, COMPOUNDING INNOVATION
AND SCOTT E. OWENS), FROM ANY AND ALL LIABILITY, CLAIM, DAMAGE, SUIT, COST,
EXPENSE OR OBLIGATION OF ANY NATURE WHATSOEVER, WHETHER KNOWN OR UNKNOWN,
ARISING IN RESPECT OF OR IN CONNECTION WITH ANY TIME OR PERIOD OF TIME ON OR
PRIOR TO THE CLOSING DATE, EXCEPT WITH RESPECT TO OBLIGATIONS ARISING UNDER THIS
AGREEMENT AND DOCUMENTS EXECUTED IN CONNECTION WITH THIS AGREEMENT INCLUDING
WITHOUT LIMITATION THAT CERTAIN MEMORANDUM OR UNDERSTANDING OF EVEN DATE
HEREWITH AND THE CONFIDENTIALITY AGREEMENT OF EVEN DATE HEREWITH BY AND AMONG
INTERSYSTEMS, BPI AND SCOTT E. OWENS.

            (c) SCOTT E. OWENS HEREBY AGREES AND CONFIRMS THAT EFFECTIVE FROM
AND AFTER THE CLOSING, HE HEREBY FULLY RELEASES, ACQUITS AND FOREVER DISCHARGES
THE STOCKHOLDER AND INTERSYSTEMS, TOGETHER WITH THEIR OFFICERS AND DIRECTORS,
SUCCESSORS, ASSIGNS, AFFILIATES, AND PARENTS FROM ANY AND ALL LIABILITY, CLAIM,
DAMAGE, SUIT, COST, EXPENSE OR OBLIGATION OF ANY NATURE WHATSOEVER, WHETHER
KNOWN OR UNKNOWN, ARISING IN RESPECT OF OR IN CONNECTION WITH ANY TIME OR PERIOD
OF TIME ON OR PRIOR TO THE CLOSING DATE, EXCEPT WITH RESPECT TO OBLIGATIONS
ARISING UNDER THIS AGREEMENT AND DOCUMENTS EXECUTED IN CONNECTION WITH THIS
AGREEMENT INCLUDING WITHOUT LIMITATION THAT CERTAIN MEMORANDUM OF UNDERSTANDING
OF EVEN DATE HEREWITH AND THE CONFIDENTIALITY AGREEMENT OF EVEN DATE HEREWITH BY
AND AMONG INTERSYSTEMS, BPI AND SCOTT E. OWENS.

            (d) THE COMPANY HEREBY AGREES AND CONFIRMS THAT EFFECTIVE FROM AND
AFTER THE CLOSING, IT HEREBY FULLY RELEASES, ACQUITS AND FOREVER DISCHARGES THE
STOCKHOLDER AND INTERSYSTEMS, TOGETHER WITH THEIR OFFICERS AND DIRECTORS,
SUCCESSORS, ASSIGNS, AFFILIATES, AND PARENTS FROM ANY AND ALL LIABILITY, CLAIM,
DAMAGE, SUIT, COST, EXPENSE OR OBLIGATION OF ANY NATURE WHATSOEVER, WHETHER
KNOWN OR UNKNOWN, ARISING IN RESPECT OF OR IN CONNECTION WITH ANY TIME OR PERIOD
OF TIME ON OR PRIOR TO THE CLOSING DATE, EXCEPT WITH

                                       19
<PAGE>
RESPECT TO OBLIGATIONS ARISING UNDER THIS AGREEMENT AND DOCUMENTS EXECUTED IN
CONNECTION WITH THIS AGREEMENT INCLUDING WITHOUT LIMITATION THAT CERTAIN
MEMORANDUM OF UNDERSTANDING OF EVEN DATE HEREWTIH.

      5.6. CHARACTERIZATION FOR TAXATION PURPOSES.

            (a) Compounding Innovation and Stockholder agree to join in making
an election, within twenty (20) days after the Closing Date, under Section
338(h)(10) of the Code and the treasury regulations and any corresponding or
similar elections under state, local or foreign tax law (collectively, the
"Section 338(h)(10) Election") with respect to the purchase and sale of the
Shares hereunder.

            (b) Compounding Innovation and Stockholder shall be jointly
responsible for the preparation and filing of all forms and documents required
in connection with the Section 338(h)(10) Election and shall agree on the
valuations and allocations of the Purchase Price. For the purpose of making the
Section 338(h)(10) Election, on or prior to the Closing Date, Compounding
Innovation and Stockholder shall execute two copies of Internal Revenue Service
Form 8023-A (or successor form). Stockholder shall execute (or cause to be
executed) and deliver to Compounding Innovation such additional documents or
forms as are necessary to complete properly the Section 338(h)(10) Election and
are consistent with the terms and provisions of this Section 5.6. In the event
Compounding Innovation and Stockholder cannot prepare all forms necessary to
effectuate the 338(h)(10) election prior to Closing, the parties agree to
prepare and file all relevant forms as soon as practicable after Closing, but in
no event more than 45 days after Closing unless mutually agreed to by
Compounding Innovation and Stockholder.

            (c) Compounding Innovation and Stockholder shall file, and shall
cause their Affiliates to file, all Tax returns and statements, forms and
Schedules in connection therewith in a manner consistent with the Section
338(h)(10) Election and such valuations and shall take no position contrary
thereto unless required to do so by applicable Tax laws.

            (d) To the extent permitted by state, local or foreign tax laws, the
principles and procedures of this Section 5.9 shall also apply with respect to a
Section 338(h)(10) Election or equivalent or comparable provision under state,
local or foreign law, including but not limited to an election under Section
338(g) of the Code or equivalent or comparable provision under state, local or
foreign law. Compounding Innovation shall make or cause to be made any election
similar to a Section 338(h)(10) Election that is optional under any state, local
or foreign law with the valuations and allocation and treatment of the Purchase
Price agreed to pursuant to this Section 5.6, and shall cooperate and join in
any election made by Stockholder or its Affiliates to effect such an election so
as to treat the sale of the Shares contemplated herein as a sale of assets for
state, local and foreign income tax purposes.

      5.7. ASSUMPTION OF 401K PLAN. As of the Closing, the Company or
Compounding Innovation shall adopt, assume and continue the InterSystems 401k
Savings and Profit Sharing Plan (the "401k Plan") current administered by
InterSystems. InterSystems shall use reasonable commercial efforts to cause the
401k Plan to be assumed and administered by the Company or Compounding
Innovation.

                                       20
<PAGE>
      5.8. INSURANCE. The Company's general liability insurance policy and any
umbrella liability policy shall provide that Stockholder shall be named as an
additionally insured party under such policy. Nothing contained in this Section
5.8 shall require the Company to maintain any insurance or any particular level
of insurance.

6.    CONDITIONS PRECEDENT TO OBLIGATIONS OF INTERSYSTEMS AND STOCKHOLDERS

      The obligation of Stockholder to close the transactions set forth in this
Agreement is, at their option, subject to the following conditions:

      6.1. REPRESENTATIONS AND WARRANTIES; PERFORMANCE OF OBLIGATIONS. The
representations and warranties of Compounding Innovation contained in Section 4
shall be accurate as of the Closing Date as though such representations and
warranties had been made as of that time; all of the terms, covenants and
conditions of this Agreement to be complied with and performed by Compounding
Innovation on or before the Closing Date shall have been duly complied with and
performed, including the material performance of all obligations of Compounding
Innovation; and a certificate to the foregoing effect dated as of the Closing
Date and signed by Compounding Innovation shall have been delivered to the
Stockholder.

      6.2. COUNSEL APPROVAL. All actions, proceedings, instruments and documents
required to carry out this Agreement or incidental hereto and all other related
legal matters shall have been approved by counsel to Stockholder.

      6.3. COMPANY DISTRIBUTION. The distribution as described in Section 1.1
shall have been approved by the Board of Directors and the transactions
contemplated by Section 1.1 shall have been consummated.

      6.4. NO LITIGATION. No action or proceeding before a court or any other
governmental agency or body shall have been instituted or threatened to restrain
or prohibit the acquisition by Compounding Innovation of the Shares and no
governmental agency or body shall have taken any other action or made any
request of the Company as a result of which the management of the Company deems
it inadvisable to proceed with the transactions hereunder.

      6.5. RELEASE OF GUARANTEES. Stockholder and InterSystems shall have been
fully released from all obligations under guarantees of the Company's
obligations, including, without limitation, guarantees of the Company's
obligations to The Frost National Bank and Financial Federal Credit Inc.

7.    CONDITIONS TO OBLIGATIONS OF COMPOUNDING INNOVATION

      The obligation of Compounding Innovation to close the transactions set
forth in this Agreement is, at its option, subject to the satisfaction, on or
prior to the Closing Date, of the following conditions:

      7.1. REPRESENTATIONS AND WARRANTIES; PERFORMANCE OF OBLIGATIONS. The
representations and warranties of Stockholder contained in Section 3 shall be
accurate as of the Closing Date as though such representations and warranties
had been made as of that time; all of

                                       21
<PAGE>
the terms, covenants and conditions of this Agreement to be complied with and
performed by Stockholder on or before the Closing Date shall have been duly
complied with and performed including the material performance of all
obligations of the Stockholder; and a certificate to the foregoing effect dated
as of the Closing Date and signed by the Stockholder shall have been delivered
to Compounding Innovation.

      7.2. COUNSEL APPROVAL. All actions, proceedings, instruments and documents
required to carry out this Agreement or incidental hereto and all other related
legal matters shall have been approved by counsel to Compounding Innovation.

      7.3. NO LITIGATION. No action or proceeding before a court or any other
Government Authority shall have been instituted or threatened to restrain or
prohibit the acquisition by Compounding Innovation of the Shares and no
governmental agency or body shall have taken any other action or made any
request of Compounding Innovation as a result of which Compounding Innovation
deems it inadvisable to proceed with the transactions hereunder.

      7.4. OPINION OF COUNSEL. Compounding Innovation shall have received an
opinion from St. John & Wayne, counsel to Stockholder, dated the Closing Date,
substantially in the form attached hereto as Exhibit A and otherwise in form and
substance reasonably satisfactory to and addressed to Compounding Innovation and
dated the Closing Date. In rendering such opinion, counsel may rely upon
certificates of public officials and upon certificates of officers of
Stockholder as to factual matters and on opinions of other counsel of good
standing whom such counsel believes to be reliable as to matters with respect to
which the laws of jurisdictions other than New York are applicable and copies of
which have been provided to Compounding Innovation.

      7.5. CONSENTS AND APPROVALS. All necessary consents of and filings with
any Government Authority or any other Person relating to the consummation of the
transaction contemplated herein shall have been obtained or made, as applicable,
and no Person shall have taken any other action or made any request of
Compounding Innovation as a result of which Compounding Innovation deems it
inadvisable to proceed with the transactions hereunder.

      7.6. GOOD STANDING CERTIFICATES. Stockholder shall have delivered to
Compounding Innovation a certificate, dated as of a date no longer than ten (10)
days prior to the Closing Date, duly issued by the appropriate governmental
authority in the State of Delaware and, unless waived by Compounding Innovation,
in each state in which the Company is authorized to do business, showing the
Company is in good standing and authorized to do business and that all state
franchise and/or income tax returns have been filed and taxes paid for the
Company for all periods prior to the Closing.

      7.7. FIRPTA AFFIDAVITS. Compounding Innovation shall have received from
Stockholder and each other person required under the Code to deliver the same in
connection with the transactions contemplated by this Agreement an affidavit
under and in accordance with Section 897 and Section 1445 of the Code.

      7.8. FINANCING. Compounding Innovation shall have obtained as of the
Closing financing from one or more financing sources for (i) the payment of all
amounts payable by Compounding Innovation in connection with the Closing and
(ii) the operation and growth of the

                                       22
<PAGE>
Company after the Closing, in each case in amounts, and on terms and conditions,
satisfactory to Compounding Innovation in Compounding Innovation' sole
discretion.

8.    INDEMNIFICATION

      8.1. SURVIVAL. The representations, warranties, covenants and agreements
of the parties made in this Agreement shall survive (and not be affected in any
respect by) the Closing. Notwithstanding the foregoing, the representations and
warranties and the right of indemnification with respect to each representation
and warranty contained in this Agreement shall terminate on the date (the
"Survival Date") occurring sixty (60) days after the first (1st) anniversary of
the Closing Date; provided, however, that the right to indemnification with
respect to the representations and warranties set forth in (i) Sections 3.1,
3.2, 3.3, 3.4, 4.1 and 4.2 shall survive indefinitely, and (ii) Sections 3.14,
3.16, and 3.22 shall survive until thirty days after the expiration of the
applicable statute of limitations (or extensions or waivers thereof) relating to
the matters set forth in such Sections. The right to indemnification with
respect to such representations and warranties, and the liability of either
party with respect thereto, shall not terminate with respect to any claim,
whether or not fixed as to liability or liquidated as to amount, with respect to
which such party has been given written notice prior to the Survival Date or
such thirtieth day after the expiration of the applicable statute of limitations
(or extensions or waivers thereof), whichever shall be applicable thereto in
accordance with this Section 8.1.

      8.2. INDEMNIFICATION BY STOCKHOLDER. Stockholder and InterSystems shall
jointly and severally indemnify, defend, protect and hold harmless Compounding
Innovation and the Company, each of their respective successors and assigns and
each of their respective directors, officers, employees, attorneys, agents and
affiliates (each a "Compounding Innovation Indemnified Person"), at all times
from and after the date of this Agreement (subject to any limitation on the
survival of representations and warranties set forth in Section 8.1) against all
losses, claims, damages, actions, suits, proceedings, demands, assessments,
adjustments, costs and expenses ("Losses") (including specifically, but without
limitation, reasonable attorneys' fees and expenses of investigation ("Legal
Expenses")) based upon, resulting from or arising out of (a) any inaccuracy or
breach of any representation or warranty of Stockholder or InterSystems
contained in this Agreement (it being understood that, notwithstanding anything
to the contrary contained in this Agreement, to determine if there has been an
inaccuracy or breach of a representation or warranty of Stockholder or
InterSystems and the Losses arising from such inaccuracy or breach, such
representation or warranty shall be read as if it were not qualified by
materiality, including, without limitation, qualifications indicating accuracy
"in all material respects" or accuracy except to the extent the inaccuracy will
not have a "Material Adverse Effect") and (b) the breach by Stockholder or
InterSystems of, or the failure by Stockholder or InterSystems to observe, any
of the covenants or other agreements contained in this Agreement; provided,
however, that Compounding Innovation shall have no recourse against the
Stockholder or InterSystems unless and to the extent the aggregate amount of its
claims under this Agreement exceeds $50,000. Stockholder's and InterSystems'
aggregate liability in respect of all claims for breach of representations and
warranties shall not exceed $700,000 in the aggregate.

      8.3. INDEMNIFICATION BY COMPOUNDING INNOVATION OR THE COMPANY. Compounding
Innovation and the Company shall jointly and severally indemnify, defend,
protect and hold harmless Stockholder and InterSystems, their successors and
assigns and each of their respective directors, officers, employees, attorneys,
agents and affiliates (each a

                                       23
<PAGE>
"Stockholder Indemnified Person") at all times from and after the date of this
Agreement (subject to any limitation on the survival of representations and
warranties set forth in Section 8.1) against all Losses (including specifically,
but without limitation, Legal Expenses) based upon, resulting from or arising
out of (a) any inaccuracy or breach of any representation or warranty of
Compounding Innovation contained in this Agreement, (b) the breach by
Compounding Innovation of, or the failure by Compounding Innovation to observe,
any of its covenants or other agreements contained in or made pursuant to this
Agreement, (c) the breach by the Company or the failure by the Company to
observe any of its covenants and agreements set forth in Article 5, and (d) the
conduct of the Company after the Closing.

      8.4. INDEMNIFICATION PROCEDURES.

            (a) Promptly after receipt by any person entitled to indemnification
under Section 8.2 or 8.3 (an "indemnified party") of notice of the commencement
of any action, suit or proceeding by a person not a party to this Agreement in
respect of which the indemnified party will seek indemnification hereunder (a
"Third Party Action"), the indemnified party shall notify the person that is
obligated to provide such indemnification (the "indemnifying party") thereof in
writing, but any failure to so notify the indemnifying party shall not relieve
it from any liability that it may have to the indemnified party under Section
8.2 or 8.3, except to the extent that the indemnifying party is prejudiced by
the failure to give such notice. The indemnifying party shall be entitled to
participate in the defense of such Third Party Action and to assume control of
such defense (including settlement of such Third Party Action) with counsel
reasonably satisfactory to such indemnified party; provided, however, that:

                  (i) the indemnified party shall be entitled to participate in
the defense of such Third Party Action and to employ counsel at its own expense
(which shall not constitute Legal Expenses for purposes of this Agreement) to
assist in the handling of such Third Party Action;

                  (ii) the indemnifying party shall obtain the prior written
approval of the indemnified party before entering into any settlement of such
Third Party Action or ceasing to defend against such Third Party Action, if
pursuant to or as a result of such settlement or cessation, injunctive or other
equitable relief would be imposed against the indemnified party or the
indemnified party would be materially adversely affected thereby;

                  (iii) no indemnifying party shall consent to the entry of any
judgment or enter into any settlement that does not include as an unconditional
term thereof the giving by each claimant or plaintiff to each indemnified party
of a release from all liability in respect of such Third Party Action; and

                  (iv) the indemnifying party shall not be entitled to control
the defense of any Third Party Action unless the indemnifying party confirms in
writing its assumption of such defense and continues to pursue the defense
reasonably and in good faith.

After written notice by the indemnifying party to the indemnified party of its
election to assume control of the defense of any such Third Party Action in
accordance with the foregoing, (i) the indemnifying party shall not be liable to
such indemnified party hereunder for any Legal Expenses subsequently incurred by
such indemnified party attributable to defending against such

                                       24
<PAGE>
Third Party Action, and (ii) as long as the indemnifying party is reasonably
contesting such Third Party Action in good faith, the indemnified party shall
not admit any liability with respect to, or settle, compromise or discharge the
claim underlying, such Third Party Action without the indemnifying party's prior
written consent. If the indemnifying party does not assume control of the
defense of such Third Party Action in accordance with this Section 8.4, the
indemnified party shall have the right to defend and/or settle such Third Party
Action in such manner as it may deem reasonably appropriate at the cost and
expense of the indemnifying party provided that the indemnifying party has
received written notice of the proposed settlement and the terms thereof, and
the indemnifying party will promptly reimburse the indemnified party therefor in
accordance with this Section 8. The reimbursement of fees, costs and expenses
required by this Section 8 shall be made by periodic payments during the course
of the investigation or defense, as and when bills are received or expenses
incurred.

            (b) If an indemnified party becomes entitled to any indemnification
from an indemnifying party pursuant to this Agreement, such indemnification
payment shall be made in cash upon demand.

            (c) If an indemnified party has actual knowledge of any facts or
circumstances other than the commencement of a Third Party Action which cause in
good faith it to believe that it is entitled to indemnification under this
Section 8, then such indemnified party shall promptly give the indemnifying
party notice thereof in writing, but any failure to so notify the indemnifying
party shall not relieve it from any liability that it may have to the
indemnified party under Section 8.2 or 8.3, as the case may be, except to the
extent that the indemnifying party is prejudiced by the failure to give such
notice.

            (d) All payments made under this Section 8 shall be made by wire
transfer in immediately available funds in U.S. dollars.

            (e) The parties hereto agree that if InterSystems or Stockholder
becomes liable to any Compounding Innovation indemnified party pursuant to
Section 8.2 hereof, Compounding Innovation shall have the right, in addition to
Compounding Innovation rights hereunder, at law or in equity, to withhold or
offset any amount payable to Stockholder under the Promissory Note and/or
Guaranty delivered to Stockholder pursuant to this Agreement, but only to the
extent of such liability and in no event shall Compounding Innovation or the
Company withhold or offset an amount in excess of $150,000 in the aggregate
under the Promissory Note. Neither Compounding Innovation nor the Company will
offset any amount payable to Stockholder pursuant to Section 1 hereof or with
respect to any similar relationship with Mytex or its Affiliates for the benefit
of Mytex.

            (f) Notwithstanding anything to the contrary herein, an indemnifying
party shall not be liable for Losses arising out of or in connection with any
matter described in this Section 8 if and to the extent such Losses are covered
by a policy of insurance or benefits from a right to indemnification from a
Person not a party to this Agreement and payment is made under such policy to
the indemnified party by the insurer or under such right to indemnification by
such Person, as applicable.

                                       25
<PAGE>
            (g) The remedies provided in this Section 8 shall be the exclusive
remedy for monetary damages (whether at law or in equity) with respect to
matters subject to indemnification under Section 8.2(a) or Section 8.3(a)
hereof.

9.    NONCOMPETITION

      9.1. PROHIBITED ACTIVITIES.

      Stockholder and InterSystems hereby jointly and severally covenant,
acknowledge and agree as follows:

            (a) For a period of five (5) years after the Closing (except as set
forth in the following paragraph), neither Stockholder nor InterSystems nor any
of their Affiliates shall for any reason whatsoever, directly or indirectly, for
itself or on behalf or in conjunction with any other person, persons, company,
partnership, corporation or business of whatever nature engage, as a
shareholder, owner, partner, joint venturer, or in any capacity, whether as a
contractor, consultant or advisor in any plastic compounding business that is
located in the United States of America.

Notwithstanding the foregoing provisions of this paragraph, Stockholder may (i)
be a passive investor owning no more than 5% of the outstanding equity
securities of any corporation the equity securities of which are listed on a
national securities exchange or traded on the NASDAQ National Market System and
with which Stockholder has no other connection whatsoever or (ii) provide
financial assistance to any Person pursuant to a factoring or other lending
arrangement provided such arrangement does not result in Stockholder,
InterSystems or their respective affiliates owning securities representing (or
convertible into) more than 5% of the outstanding equity securities of such
entity;

            (b) For a period of five (5) years neither InterSystems nor
Stockholder shall and shall cause each of its Affiliates not to, offer to employ
any person who is, at that time, or who has been within one (1) year prior to
that time, an employee of Compounding Innovation or the Company;

            (c) For a period of five (5) years after the Closing Date, neither
InterSystems nor Stockholder shall and shall cause each of its Affiliates to,
engage or participate in any effort or act to induce any customer, supplier,
associate, employee, sales or other agent or independent contractor of
Compounding Innovation or the Company or which has been a customer, supplier,
employee, sales or other agent or independent contractor of Compounding
Innovation or the Company within one (1) year prior to that time, to take any
action which might be disadvantageous to Compounding Innovation or the Company,
or to not take any action which might be advantageous to Compounding Innovation
or the Company in the plastics compounding business;

            (d) Stockholder and InterSystems acknowledge that the damages that
would be suffered by Compounding Innovation as a result of any breach of the
provisions of this Section 9.1 may not be calculable and that an award of a
monetary judgment for such a breach would be an inadequate remedy. Consequently,
Compounding Innovation shall have the right, in addition to any other rights it
may have, to obtain, in any court of competent jurisdiction, injunctive relief
to restrain any breach or threatened breach of any provision of this Section 9.1
or otherwise to

                                       26
<PAGE>
specifically enforce any of the provisions hereof, and Compounding Innovation
shall not be obligated to post a bond or other security in seeking such relief.
This remedy is in addition to damages directly or indirectly suffered by
Compounding Innovation and reasonable attorneys fees;

            (e) It is agreed by the parties that the foregoing covenants in this
Section 9.1 impose a reasonable restraint on InterSystems and Stockholder in
light of the activities and business of the Company and Compounding Innovation
on the date of the execution of this Agreement and the current plans of
Compounding Innovation; and

            (f) The parties hereto agree that the duration and area for which
the covenants in this Section 9.1 are to be effective are reasonable. In the
event that any court finally determines that the time period or the geographic
scope of any such covenant is unreasonable or excessive and any covenant is to
that extent made unenforceable, the parties agree that the restrictions of this
Section 9.1 shall remain in full force and effect for the greatest time period
and within the greatest geographic area that would not render it unenforceable.
The parties intend that each of the covenants in Sections 9.1 (a), (b), (c), (d)
and (e) shall be deemed to be a separate covenant.

            9.2. INDEPENDENT COVENANT. All of the covenants in this Section 9
shall be construed as an agreement independent of any other provision of this
Agreement, and the existence of any claim or cause of action of Stockholder or
InterSystems against the Company or Compounding Innovation, whether predicated
on this Agreement or otherwise, shall not constitute a defense to the
enforcement by Compounding Innovation or the Company of such covenants. It is
specifically agreed that the period of five (5) years stated above, shall be
computed by excluding from such computation any time during which any
Stockholder is in violation of any provision of this Section 9 and any time
during which there is pending in any court of competent jurisdiction any action
(including any appeal from any judgment) brought by any person, whether or not a
party to this Agreement, in which action Compounding Innovation or the Company
seeks to enforce the agreements and covenants of Stockholder or InterSystems in
this Section 9 or in which any person contests the validity of such agreements
and covenants or their enforceability or seeks to avoid their performance or
enforcement.

      9.3. MATERIALITY. Stockholder hereby agrees that this covenant is a
material and substantial part of this transaction.

10.   CERTAIN DEFINITIONS

      "Affiliate" (whether or not capitalized) shall mean, with respect to any
person, any other person that directly, or through one or more intermediaries,
controls or is controlled by or is under common control with such first person.
As used in this definition, "control" shall mean possession, directly or
indirectly, of power to direct or cause the direction of management or policies
(whether through ownership of securities or other ownership interest, by
contract or otherwise).

      "Business Day" means each day other than a Saturday, a Sunday, a legal
holiday or a day on which commercial banks are authorized or required to be
closed in Houston, Texas.

      "Code" means the Internal Revenue Code of 1986, as amended from time to
time, and the regulations promulgated and rulings issued thereunder. Section
references to the Code are to the

                                       27
<PAGE>
Code as in effect at the date of this Agreement and any subsequent provisions of
the Code amendatory thereof, supplemental thereto or substituted therefor.

      "Compounding Innovation Group" shall mean (a) Compounding Innovation or
Scott E. Owens, (b) any current or former employee of the Company that reports
or reported directly or indirectly to Scott E. Owens, (c) any current or former
consultant of the Company that was hired by Compounding Innovation or Scott E.
Owens or any current or former employee of the Company that reports or reported
directly or indirectly to Compounding Innovation or Scott E. Owens or any
affiliate of the foregoing (other than the Company).

      "Encumbrances" shall mean mortgages, liens, pledges, encumbrances (legal
or equitable), claims, charges, security interests, covenants, conditions,
voting and other restrictions, rights-of-way, easements, options, encroachments,
rights of others and any other matters affecting title, except, in the case of
the Shares, for restrictions on the sale or other disposition thereof imposed by
federal or state securities laws.

      "GAAP" shall mean generally accepted accounting principles.

      "Government Authority" shall mean any government or state (or any
subdivision thereof), whether domestic, foreign or multinational, or any agency,
authority, bureau, commission, department or similar body or instrumentality
thereof, or any government court or tribunal.

      "Knowledge" shall mean facts that are actually known by Stockholder or
InterSystems or any employee, officer, director, or agent of the Company,
Stockholder or InterSystems (without any duty to investigate) other than any
member of the Compounding Innovation Group.

      "Legal Requirement" shall mean any law, statute, ordinance, code, rule,
regulation, standard, judgment, decree, writ, ruling, arbitration award,
injunction, order or other requirement of any Government Authority.

      "Person" (whether or not capitalized) shall mean and include an
individual, corporation, company, limited liability company, limited liability
partnership, partnership, joint venture, association, trust, and other
unincorporated organization or entity including any Government Authority.

      "Material Adverse Effect" shall mean any material adverse change in or
effect on, or any change that may reasonably be expected to have a material
adverse effect on, (i) the business, operations, assets, liabilities, condition
(financial or otherwise), results of operations, or prospects of the Company or
(ii) the ability of the Company or Stockholder to consummate the transactions
contemplated by this Agreement or any related agreement to which it is a party.

      "Mytex" means Mytex Polymers.

      "Mytex Agreement" means the Definitive Agreement for Compounding Services
dated January 26, 1996, between Mytex and the Company, as amended and in effect
from time to time; and the Mytex Agreement together with all other contracts,
agreements, arrangements or relationships between the Company and Mytex or
otherwise related to the agreements, transaction or business with Mytex are
referred to herein as the "Mytex Agreements."

                                       28
<PAGE>
      "Section 338(h)(10) Election" is defined in Section 5.9.

      "Technology" shall mean all trade secrets, proprietary information,
software and computer programs and source code date relating thereto (including
all current and historical data bases) research records, test information,
market surveys, marketing know-how, inventories, know-how, process and
procedures owned, used by or licensed to the Company.

11.   GENERAL

      11.1. COOPERATION. Stockholder and Compounding Innovation shall each
deliver or cause to be delivered to the other on the Closing Date, and at such
other times and places as shall be reasonably agreed to, such additional
instruments as the other may reasonably request for the purpose of carrying out
this Agreement. To the extent reasonably requested by Compounding Innovation and
at Compounding Innovation's expense, Stockholder will cooperate and use their
best reasonable efforts to have the present officers, directors and employees of
the Company cooperate with Compounding Innovation, on and after the Closing Date
in furnishing information, evidence, testimony and other assistance in
connection with any actions, proceedings, arrangements or disputes of any nature
with respect to matters pertaining to all periods prior to the Closing Date.

      11.2. DESIGNEE; SUCCESSORS AND ASSIGNS. This Agreement and the rights of
the parties hereunder may not be assigned and shall be binding upon and shall
inure to the benefit of the parties hereto, the successors, heirs and legal
representatives of Compounding Innovation, and the successors and permitted
assigns of Stockholder.

      11.3. ENTIRE AGREEMENT. This Agreement (including the Exhibits attached
hereto and the SCHEDULEs delivered pursuant hereto) and the other writings
specifically identified herein or contemplated hereby contain the entire
agreement and understanding between Stockholder and Compounding Innovation with
respect to the transactions contemplated herein and supersede any prior
agreement and understanding relating to the subject matter of this Agreement.
This Agreement may be modified or amended only by a written instrument executed
by Compounding Innovation and Stockholder acting through its duly authorized
officers.

      11.4. COUNTERPARTS. This Agreement may be executed simultaneously in two
or more counterparts, each of which shall be deemed an original and all of which
together shall constitute but one and the same instrument.

      11.5. BROKERS AND AGENTS. Each party represents and warrants that it
employed no broker or agent in connection with this transaction and agrees to
indemnify the other against all loss, cost, damages or expense arising out of
claims for fees or commission of brokers employed or alleged to have been
employed by such indemnifying party.

      11.6. PAYMENT OF EXPENSES. Each of the parties hereto shall pay all its
own costs and expenses incurred in connection with this Agreement and the
transactions contemplated hereby. The fees and expenses for outside legal,
accounting, and financial advice to the Company that are incurred at the request
or direction of Walter M. Craig, Daniel T. Murphy or their affiliates,
representatives or agents other than the Compounding Innovations Group and
Stockholder incurred in connection with the transactions provided for in this
Agreement shall be payable by Stockholder.

                                       29
<PAGE>
      11.7. NOTICES. All notices of communication required or permitted
hereunder shall be in writing and may be given by depositing the same in United
States mail, addressed to the party to be notified, postage prepaid and
registered or certified with return receipt requested, or by delivering the same
in person.

            (a) If to Compounding Innovation, addressed to:

                  Compounding Innovation, Inc.
                  7115 Clinton Drive
                  Houston, Texas  77020
                  (713) 675-1616 - Telephone
                  (713) 675-3944 - Facsimile

                  Mayor, Day, Caldwell & Keeton, L.L.P.
                  700 Louisiana, Suite 1900
                  Houston, Texas  77002
                  Attn:  Geoffrey Walker
                  (713) 225-7023 - Telephone
                  (713) 225-7047 -Facsimile

            (b) If to Stockholder or InterSystems, addressed to:

                  InterSystems, Inc.
                  1011 Highway 71
                  Springlake, New Jersey  07762
                  Attn:  Walter M. Craig, Jr.
                  (732) 282-1411 - Telephone
                  (732) 282-1811 - Facsimile

      11.8. GOVERNING LAW. This Agreement shall be construed in accordance with
the laws of the State of Texas.

      11.9. EXERCISE OF RIGHTS AND REMEDIES. Except as otherwise provided
herein, no delay of or omission in the exercise of any right, power or remedy
accruing to the party as a result of any breach or default by the other party
under this Agreement shall impair any such right, power or remedy, nor shall it
be construed as a waiver of or acquiescence in any such breach or default, or of
any similar breach or default occurring later; nor shall any waiver of any
single breach or default be deemed a waiver of any other breach or default
occurring before or after that waiver.

      11.10. TIME. Time is of the essence in this Agreement.

      11.11. REFORMATION AND SEVERABILITY. In case any provision of this
Agreement shall be invalid, illegal or unenforceable, it shall, to the extent
possible, be modified in such a manner as to be valid, legal and enforceable but
so as to most nearly retain the intent of the parties, and if such modification
is not possible, such provision shall be severed from this Agreement, and in
either case the validity, legality and enforceability of the remaining
provisions of this Agreement shall not in any way be affected or impaired
thereby.

                                       30
<PAGE>
      IN WITNESS WHEREOF, the parties hereto have executed this Agreement as of
the day and year first above written.

                                        COMPOUNDING INNOVATION, INC.

                                        By:_____________________________________
                                        Name:___________________________________
                                        Title:__________________________________

                                        CHEMTRUSION, INC.

                                        By:_____________________________________
                                        Name:___________________________________
                                        Title:__________________________________

                                        INTERSYSTEMS, INC.

                                        By:_____________________________________
                                        Name:___________________________________
                                        Title:__________________________________

                                        BPI LIQUIDATION CORP.

                                        By:_____________________________________
                                        Name:___________________________________
                                        Title:__________________________________

                                       31<PAGE>

                                                                    EXHIBIT 10.8

                           MEMORANDUM OF UNDERSTANDING

      This MEMORANDUM OF UNDERSTANDING is entered into as of the _____ day of
September, 2001 (the "Effective Date"), by and between BPI LIQUIDATION CORP.
("BPI") and CHEMTRUSION, INC. ("Chemtrusion"), a Delaware corporation.

      WHEREAS, on September __, 2001, the Board of Directors of Chemtrusion
approved and declared a dividend to BPI (as defined below) effective as of the
date hereof, of the Distributed Amount (as defined below); and

      WHEREAS, the parties hereto wish to acknowledge their understanding
regarding the Distributed Amount and agree to and clarify the procedures to be
utilized to effectuate payment of the Distributed Amount.

      NOW, THEREFORE, in consideration of the premises, representations,
warranties, covenants and agreements set forth below, and for other good and
valuable consideration, the receipt and sufficiency of which is hereby
acknowledged, the parties hereto agree as follows:

1.    Payment of the Management Fee.

      (a) As of September __, 2001, Chemtrusion distributed to BPI the right to
receive the Distributed Amount (as defined below). BPI shall hold all right,
title and interest in the Distributed Amount from and after the date hereof. For
purposes of this Agreement, the Distributed Amount shall mean for each calendar
year prior to January 1, 2007, such amount of the "Management Fee," as defined
in the "Definitive Agreement" (as hereinafter defined) as equals the following
amount:

      (i)   for the calendar year 2001, 50% of the Management Fee up to $150,000
            plus the Supplemental Amount; and

      (ii)  for each subsequent calendar year through and including December 31,
            2006 only, 50% of the Management Fee up to an amount equal to: the
            sum of (a) $400,000.00, plus (b) the Supplemental Amount (as defined
            below), if any (the sum of $150,000 plus the Supplemental Amount for
            the year 2001 and the sum of $400,000 plus the Supplemental Amount
            for each year thereafter is referred to as the "Maximum Annual
            Amount").

The term "Definitive Agreement" shall refer to that certain agreement for
Compounding Services, dated as of January 26, 1996, between Mytex Polymers and
Chemtrusion, as such agreement has been or may hereafter be amended. The term
"Supplemental Amount" means for any calendar year or portion thereof the sum of
the "Monthly Supplemental Amounts" for such calendar year or portion thereof;
the term "Monthly Supplemental Amount" shall mean for a particular month, the
product of (x) $33,333.33, times (y) the percentage amount, if any, by which the
annual Fixed Fee (as defined in the Definitive Agreement) in effect on the first
(1st) day of such month exceeds $1,035,000.00. Chemtrusion shall timely
calculate and provide to BPI the Monthly Supplemental Amount in effect on the
first day of each calendar month prior to December 31, 2006, and shall also
promptly, but in no event more than two (2) business days
<PAGE>
after the invoice is delivered to Mytex, provide copies of all monthly invoices
for the Management Fee delivered to Mytex. In addition, Chemtrusion shall
promptly provide notice to InterSystems, Inc., a Delaware corporation
("InterSystems") of the construction completion date for each new facility or
line installed at the Plant (as defined in the Definitive Agreement) pursuant to
Article XII of the Definitive Agreement prior to December 31, 2006. Payments to
BPI of the Distributed Amount shall be made within four (4) business days
following receipt of a payment of the monthly Management Fee and receipt by
Southwest Bank of Texas, N.A. ("Southwest Bank") of a Disbursement Request, as
contemplated by 1(c) below (the "Payment Date"), all in accordance with the
procedures set forth in Paragraphs 1(b) and 1(c). For purposes of determining
the amount to which BPI is entitled to be paid, the Supplemental Amount shall be
calculated for the months in the applicable calendar year through the date of
payment. To the extent less than the Maximum Annual Amount has been paid to BPI
with respect to any particular calendar year together with the sum of any
deficiency with respect to Maximum Annual Amount payments that has been carried
over from prior years, such amount shall be added to the Distributed Amount for
the next succeeding year. In the event BPI is not paid the entire monthly amount
to which it is entitled hereunder, as applicable, interest at a rate equal to
the lesser of (i) fifteen percent (15%) per annum or (ii) the highest lawful
rate shall accrue on the unpaid portion of such amount from the Due Date (as
hereinafter defined) until paid and BPI shall be permitted to pursue its
available remedies. For purposes of this Section 1(a), "Due Date" shall mean (i)
the Payment Date or (ii) four business days after a Misdirection Event and a
"Misdirection Event" shall mean (a) Chemtrusion, for any reason, causes Mytex to
make the payments referred to in Section 1(b) to any location other than
directly to the Trust Account at Southwest Bank without the written consent of
BPI or its successors or assigns and such payment is received by Chemtrusion or
its Affiliates and not promptly remitted to such Trust Account; or (b) for any
reason Mytex fails to make a payment constituting part of the Distributed Amount
to such Trust Account, and such payment is received by Chemtrusion or its
Affiliates and not promptly remitted to such Trust Account.

      (b) In order to effectuate such payments, all payments of the Management
Fee shall be paid to a Trust Account maintained at the Southwest Bank and
distributed in accordance with Paragraph 1(c) and the Escrow Agreement to be
executed among BPI, Chemtrusion and Southwest Bank. Chemtrusion shall as soon as
practicable after the date hereof, but in no event later than October 1, 2001
notify Mytex to make such payments to such account, pursuant to a Payment Notice
in the form annexed hereto as Exhibit A, which instructions shall not be
modified without BPI's prior written consent. Chemtrusion and BPI agree that
fees directly attributable to the Trust Account will be paid 50% by Chemtrusion
and 50% by BPI. The parties agree that such fees will be deducted from the
amounts distributable to the applicable party in connection with calculating the
Disbursement Calculation (as hereinafter defined).

      (c) Pursuant to the terms of the Escrow Agreement, Chemtrusion and BPI
shall provide monthly joint written instructions to Southwest Bank in the form
of a Disbursement Request setting forth the amount of the Distributed Amount and
the amount to be disbursed to Chemtrusion ("Disbursement Calculation").
Chemtrusion shall calculate the Distributed Amount and complete a Disbursement
Request contemporaneously with calculating and preparing the monthly invoice of
the Management Fee pursuant to Paragraph 1(a). Chemtrusion will deliver a
completed and executed Disbursement Request to BPI at the same time it delivers
a copy of such invoice. In the event BPI agrees with the Disbursement
Calculation, BPI shall execute and

                                       2
<PAGE>
deliver to Southwest Bank (with a copy to Chemtrusion) such Disbursement Request
in the form received from Chemtrusion. In the event BPI identifies any errors
with or otherwise disputes the Disbursement Calculation, BPI shall promptly, but
in no event more than 5 business days after receipt of the proposed Disbursement
Request, notify Chemtrusion of its disagreement specifically setting forth the
reason for such dispute and setting forth BPI's Disbursement Calculation
("Notice"). Chemtrusion and BPI will use commercially reasonable good faith
efforts to resolve any dispute and agree on the Disbursement Calculation,
including to the extent practicable, causing Scott E. Owens and Walter M. Craig
to meet and negotiate any disputes. In the event BPI unreasonably withholds or
fails to deliver the Disbursement Request to Southwest Bank within five (5)
business days of receipt from Chemtrusion (the "Delivery Date"), BPI shall pay a
"Delay Fee" (as hereinafter defined). The Delay Fee shall be equal to an amount
determined by accruing "interest" on the amount to be disbursed to Chemtrusion
at a rate of 15% per annum from the Delivery Date. In the event the parties do
not agree on the Disbursement Calculation, such dispute shall be settled by
arbitration before a single arbitrator to be selected by mutual agreement of the
parties or if the parties cannot agree in twenty days after Notice, by the
American Arbitration Association ("AAA") as arbitrator. The arbitration hearing
shall be commenced within thirty (30) days following the date of delivery of
Notice to Chemtrusion. The arbitration shall be conducted in Houston, Texas, in
accordance with the commercial arbitration rules for expedited dispute
resolution promulgated by AAA notwithstanding any threshold or value limitations
contained therein, and each party shall retain the right to cross-examine the
opposing party's witnesses, either through legal counsel, expert witnesses or
both. The decision of the arbitrator shall be final, binding and conclusive on
all parties (without any right of appeal therefrom) and shall not be subject to
judicial review. As part of his decision, the arbitrator may allocate the cost
of arbitration, including fee of attorneys and experts, as he or she deems fair
and equitable in light of all relevant circumstances. The arbitrator shall
deliver an order to Southwest Bank setting forth his decision and directing
Southwest Bank to deliver the funds in the Escrow Account to the parties as
directed by such arbitrator. Judgment on the award rendered by the arbitrator
may be entered in any court of competent jurisdiction. The amount actually
disbursed by Southwest Bank shall be equal to the amounts set forth in the
Disbursement Calculation or as ordered by the arbitrator, plus the respective
parties' pro rata portion of any interest accrued and paid on such amount based
on their respective portion of the disbursed amounts.

      (d) BPI shall have the right to audit the books and records of Chemtrusion
insofar as such books and records relate to the calculation and payment of the
Distributed Amount herein; provided, however, any audit shall be performed at
BPI's sole cost (unless as a result of such audit it is determined by BPI and
agreed by Chemtrusion that BPI was not paid at least 95% of the amount to which
it is entitled, in which case the costs, expenses and fees related to such audit
shall be borne by Chemtrusion and Chemtrusion shall promptly reimburse BPI for
any amounts it has expended with respect thereto) and conducted at Chemtrusion's
principal office during normal business hours not more than two (2) years after
the due date of the payment in question. In the event any such audit or
investigation by BPI determines or reflects that BPI has not been paid the
entire sum of the Distributed Amount to which it is entitled, Chemtrusion shall
be responsible for the payment of the portion of the Distributed Amount not so
paid, together with interest at the rate stated in paragraph 1(a) above from the
date such payment was due.

                                       3
<PAGE>
      (e) Chemtrusion agrees to provide to BPI a copy of any notice of Default
or termination given by it or Mytex, whether such notice is provided pursuant to
Section 9.2 or Section 15.6 of the Definitive Agreement.

      (f) Chemtrusion agrees that during the period from the Effective Date
until December 31, 2006, (i) neither the structure nor substance of the
Management Fee, including, without limitation, the Fixed Fee (as defined in the
Definitive Agreement) or any component thereof or the payment terms with respect
thereto shall be amended or adjusted in a manner that is adverse to BPI, without
the prior written consent of BPI, (ii) unless otherwise agreed to by BPI,
Chemtrusion's management or incentive fees relating to each new facility or line
installed at the Plant (as such term is defined in the Definitive Agreement)
prior to December 31, 2006 shall be based upon the structure and substance of
the Supplier Management Fee (including the Fixed Fee and each component thereof)
currently set forth in the Definitive Agreement, and (iii) any new facility or
line used for the compounding of products for Mytex or any of its affiliates for
the primary benefit of Mytex or its Subsidiaries that is constructed or
installed within a twenty mile radius of 1403 Port Road, Jeffersonville, Indiana
and in which Chemtrusion or any of its affiliates have any interest shall be
deemed to be part of the Plant. For purposes of this Agreement, "Subsidiary"
shall mean any entity of which Mytex owns 40% or more of its outstanding voting
securities or, in the case where it does not have voting securities, 40% or more
of its outstanding equity interests.

      2. Grant of Security Interest. Notwithstanding anything to the contrary
contained herein, for the purposes of providing additional protection of BPI's
ownership interest in the Distributed Amount, and without in any way abrogating
or implying a diminution of BPI's absolute ownership interest in the Distributed
Amount, Chemtrusion hereby grants to BPI a security interest under the
applicable uniform commercial code in the Distributed Amount and any interest
actually accrued and received thereon in the Account referenced in Section 1(b)
above, if, and to the extent, any amount constituting the Distributed Amount is
contained therein. This Memorandum of Understanding is intended to constitute a
security agreement under the applicable uniform commercial code. Chemtrusion
agrees to enter into the Subordination and Account Control Agreement and to
execute any financing statement as may be necessary, in the reasonable opinion
of BPI to establish and perfect the security interest granted above. The
security interest granted pursuant to this Section 2 shall automatically
terminate upon all Distributed Amounts being received by BPI or BPI having no
further rights to receive any amount under this Memorandum of Understanding, and
as soon as practicable after such date, BPI and its successors and assigns
agrees to undertake such additional action and execute such other documents as
may be necessary, in the reasonable opinion of Chemtrusion, to release or
terminate the security interest granted above.

      3. Complete Agreement. This Memorandum, together with the Exhibits hereto,
is the complete and exclusive agreement between the parties with respect to the
subject matter hereof, and supercedes any related prior agreements, whether oral
or written.

      4. Choice of Law. This Memorandum shall be construed and enforced under
the laws of the State of Texas, except for any rule of such laws which would
make the law of any other jurisdiction applicable.

                                       4
<PAGE>
      5. Expenses. In the event BPI is not timely paid all or any portion of the
Distributed Amount to which it is entitled, or any breach of this Agreement by
Chemtrusion hereunder, BPI shall be entitled to be paid its costs and expenses
(including, without limitation, reasonable attorneys' fees) of enforcing
Chemtrusion's obligations hereunder and obtaining payment of the Distributed
Amount.

      6. Assignment; Binding Effect. This Agreement shall be binding on, and
inure to the benefit of, the parties hereto and each of their respective
successors and assigns.

      IN WITNESS WHEREOF, the parties hereto have executed this Memorandum of
Understanding to be effective as of the Effective Date.

                                          CHEMTRUSION, INC.

                                          By:
                                             -----------------------------------
                                             Scott E. Owens, President

                                          BPI LIQUIDATION CORP.

                                          By:
                                             -----------------------------------
                                          Name:
                                               ---------------------------------
                                          Title:
                                                --------------------------------

The undersigned hereby consents to, acknowledges and accepts the understanding
set forth above effective as of this ______ day of September, 2001.

INTERSYSTEMS, INC.

By:
   -----------------------------------
Name:
     ---------------------------------
Title:
      --------------------------------

                                       5
<PAGE>
                                    EXHIBIT A

                                 PAYMENT NOTICE

Mytex Polymers
[Insert Address]

Ladies and Gentlemen:

      Until further written notice, Mytex Polymers is directed to pay the
Management Fee due Chemtrusion, Inc. pursuant to that certain Definitive
Agreement for Compounding Services dated as of January 26, 1996 (as heretofore
or hereafter amended from time to time, the "Definitive Agreement"), between
Chemtrusion, Inc. and Mytex Polymers by wire transfer in immediately available
funds, to the following account maintained in Chemtrusion, Inc.'s name and
federal identification number at Southwest Bank, N.A.:

Sincerely,

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00037-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00037-of-00352.parquet"}]]